Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1050.Time spend outdoors in summer,48347,-0.0199040968980468,0.0187148772671186,-0.0565852563415993,0.0167770625455056,0.287546035040967
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1060.Time spent outdoors in winter,44739,-0.000264025510974373,0.0211718866065984,-0.0417609232599072,0.0412328722379584,0.990050304614482
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1070.Time spent watching television (TV),49862,0.0374218681251115,0.0190509752987436,8.19565395740948e-05,0.074761779710649,0.0495059675181362
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1080.Time spent using computer,44723,-0.0560793756940546,0.0201051164761798,-0.0954854039873671,-0.0166733474007421,0.00528699757116423
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1090.Time spent driving,42167,-0.0596662252962376,0.0221495980873805,-0.103079437547503,-0.0162530130449718,0.00707125449749251
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1160.Sleep duration,51380,0.00389447078872567,0.0171880460990585,-0.029794099565429,0.0375830411428803,0.820751915982202
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,33875,-0.0156761010462149,0.022121671628812,-0.0590345774386863,0.0276823753462566,0.478571058278168
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,33875,0.0188673051983854,0.0199388257547252,-0.020212793280876,0.0579474036776467,0.344040459770362
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,33875,0.0515000970098856,0.0238589115226826,0.00473663042542766,0.0982635635943436,0.0309120780364212
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,33875,-0.0131308517658389,0.0243962058778552,-0.060947415286435,0.0346857117547572,0.590428666966516
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,33875,0.0222632734913751,0.0248172395706356,-0.0263785160670707,0.0709050630498208,0.369694327756127
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,33875,0.0516865212043419,0.047149580250761,-0.0407266560871497,0.144099698495833,0.273008590916537
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,33875,-0.0492387340790607,0.0478740854948133,-0.143071941648895,0.0445944734907733,0.303738761070469
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,33875,0.0626816541462945,0.0358512886854742,-0.00758687167723489,0.132950179969824,0.0804309183339288
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,33875,0.0673263368127575,0.025978502713945,0.0164084714934252,0.11824420213209,0.00956733240793765
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,33875,0.0143348500448224,0.0178603723266016,-0.0206714797153166,0.0493411798049615,0.42222248049124
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#18.Location of pain during the past week_Upper back,33875,-0.000296824789611039,0.0249468048311093,-0.0491925622585853,0.0485989126793633,0.990506998917562
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#19.Location of pain during the past week_Lower back,33875,0.00587659707679721,0.0152787790743579,-0.0240698099089443,0.0358230040625387,0.700524110281931
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,33875,-0.000758425425255697,0.0189552329919285,-0.0379106820894355,0.0363938312389241,0.968084884665314
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,33875,-0.00520722622525076,0.02730321152154,-0.0587215208074692,0.0483070683569677,0.848750290360606
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,33875,0.0146048232070933,0.0259015250590621,-0.0361621659086684,0.065371812322855,0.572863114476984
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,33875,0.00649231035079138,0.0365805668699876,-0.0652056007143843,0.0781902214159671,0.859135374138347
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,33875,-0.0241944033748166,0.0337228676852744,-0.0902912240379545,0.0419024172883213,0.473115506356959
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#7.Location of pain during the past week_Left hip,33875,0.0140262633129387,0.0203414717157261,-0.0258430212498843,0.0538955478757618,0.490500338155507
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#8.Location of pain during the past week_Right hip,33875,0.0312630923628541,0.0190580833006204,-0.00609075090636194,0.0686169356320701,0.100953085173468
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,33875,0.0495113549764028,0.0253748333325638,-0.000223318355422185,0.0992460283082278,0.051062944355808
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120040.Fatigue severity over the past week,33881,0.0885021074519084,0.0302132084123907,0.0292842189636225,0.147719995940194,0.00340592714780578
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120041.Waking unrefreshed severity over the past week,33878,0.051652031229108,0.0300216002229038,-0.00719030520778352,0.110494367665999,0.0853752185374422
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120042.Cognitive symptoms severity over the past week,33878,0.0594342647810824,0.0322236303121328,-0.00372405063069785,0.122592580192863,0.0651517079926447
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120098.Mobility problems today,33885,0.0449088438553047,0.0356850254887393,-0.0250338061026243,0.114851493813234,0.208249848245937
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120099.Self-care problems today,33885,0.140009260808624,0.0571382813571155,0.0280182293486773,0.25200029226857,0.0142894537129676
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120100.Problems doing usual activities,33885,0.0758393184134596,0.0337213549541983,0.00974546270323107,0.141933174123688,0.0245354961859944
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120101.Pain or discomfort today,33885,0.0306650050581492,0.0301412109255742,-0.0284117683559761,0.0897417784722745,0.308999741873193
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120102.Anxiety or depression today,33885,-0.00369033829486032,0.0354373850627816,-0.0731476130179123,0.0657669364281916,0.917062947976453
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120103.Scale to indicate how health is today,33846,-0.0118537822325168,0.00659763720771665,-0.0247851511596415,0.0010775866946078,0.0724200076569832
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,33861,0.0143101458523195,0.0366151479370254,-0.0574555441042503,0.0860758358088893,0.69593482602302
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",33837,-0.0204977588755303,0.0366100846402301,-0.0922535247703813,0.0512580070193207,0.575565253497054
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",33867,0.04460339475553,0.0298203479566985,-0.0138444872395991,0.103051276750659,0.134755755469471
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,33862,0.0866776169684765,0.0306166734174668,0.0266689370702416,0.146686296866711,0.00464925483259988
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,33870,0.0463679627477852,0.0371987769789468,-0.0265416401309504,0.119277565626521,0.212614982217467
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120109.Feeling bad about self over the last two weeks,33845,0.027047041832605,0.0385110931772835,-0.0484347007948707,0.102528784460081,0.482498149269643
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120110.Trouble concentrating over the last two weeks,33866,0.0624887445277485,0.0399527326023579,-0.0158186113728729,0.14079610042837,0.117835490120781
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,33856,0.0412216439748947,0.0585659413050376,-0.0735676009829791,0.156010888932768,0.481543556922743
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,33818,0.00201431319675052,0.0789741705404141,-0.152775061062461,0.156803687455962,0.979651926402943
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31546,0.0839651839090256,0.0399330067943439,0.00569649059211154,0.16223387722594,0.0355314265657515
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49066,-0.0182377833191791,0.0415452034880778,-0.0996663821558115,0.0631908155174533,0.660675174418783
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47259,-0.0320220684842225,0.0268697320087591,-0.0846867432213904,0.0206426062529454,0.233370733553969
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1289.Cooked vegetable intake,50854,-0.0357165853350176,0.0179715289881093,-0.0709407821517118,-0.000492388518323318,0.0468885957348602
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50368,-0.0167470111075337,0.0194265634511011,-0.0548230754716919,0.0213290532566244,0.388658291226029
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1309.Fresh fruit intake,50897,-0.027323970588376,0.0186415105498063,-0.0638613312659963,0.00921339008924422,0.142725716708117
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1319.Dried fruit intake,49188,-0.00934822123597793,0.0186555706210758,-0.0459131396532864,0.0272166971813306,0.616308420079966
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X134.Number of self-reported cancers,51666,0.0226861094594586,0.0309816840997646,-0.03803799137608,0.0834102102949973,0.464026803132614
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X135.Number of self-reported non-cancer illnesses,51666,0.0875855053140865,0.0179329167442886,0.0524369884952808,0.122734022132892,1.04510954509237e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X136.Number of operations, self-reported",51666,0.003646825080844,0.0179806677179592,-0.0315952836463561,0.0388889338080441,0.839277847616729
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X137.Number of treatments or medications taken,51666,0.0686081147615396,0.0175256443414055,0.0342578518523847,0.102958377670694,9.07269271954884e-05
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1438.Bread intake,50734,0.0186461539131151,0.00437610442756825,0.0100689892350813,0.0272233185911489,2.04311398947626e-05
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1458.Cereal intake,50283,0.0500816566278317,0.0178185730207437,0.015157253507174,0.0850060597484893,0.00494797399404397
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1488.Tea intake,50762,0.00230394150872503,0.00408684726143418,-0.00570627912368596,0.010314162141136,0.572932192593752
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1498.Coffee intake,49499,-0.0659833017030415,0.0180314232258675,-0.101324891225742,-0.0306417121803412,0.000253374048673923
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1528.Water intake,49949,-0.0259283684110543,0.0183687824441979,-0.0619311820016822,0.0100744451795735,0.158096093202208
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1568.Average weekly red wine intake,41087,-0.0616741480688726,0.0221536801582325,-0.105095361179008,-0.0182529349587369,0.00537663565378503
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41085,-0.0501185293736205,0.0221789069152447,-0.0935891869275002,-0.00664787181974083,0.0238503682365555
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1588.Average weekly beer plus cider intake,41110,0.0527794386292363,0.0280177471356586,-0.00213534575665451,0.107694223015127,0.0596113366902324
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1598.Average weekly spirits intake,41042,0.0176401838848388,0.024880425546997,-0.0311254501872754,0.066405817956953,0.478335383815625
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1608.Average weekly fortified wine intake,41117,-0.0224175341510629,0.0380118657955443,-0.0969207911103297,0.0520857228082039,0.55536562407145
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1737.Childhood sunburn occasions,45173,-0.0362202839157685,0.0214274797349635,-0.0782181441962971,0.00577757636476003,0.0909729908457687
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1807.Father's age at death,44316,-0.00264561177802766,0.00472522866933227,-0.0119070599699189,0.00661583641386358,0.575560278484092
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1845.Mother's age,35066,-0.0205482542151959,0.0107231801496127,-0.0415656873084368,0.000469178878044894,0.055360582277347
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1873.Number of full brothers,51165,0.00592687470314223,0.0173310043387133,-0.0280418938007358,0.0398956432070202,0.732367859256498
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1883.Number of full sisters,51169,-0.00851905878184586,0.0173308516770704,-0.0424875280689039,0.0254494105052122,0.623038327198873
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20015.Sitting height,51482,0.0221829597019167,0.00541696435470905,0.011565709566687,0.0328002098371465,4.23230595277334e-05
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20016.Fluid intelligence score,33194,-0.0051615816202204,0.0281782466943735,-0.0603909451411924,0.0500677819007516,0.854664092333297
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20018.Prospective memory result,33529,-0.000590225213882131,0.0376738367030207,-0.0744309451518028,0.0732504947240385,0.987500626709112
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33066,0.00626565679523362,0.00757863483747002,-0.00858846748620762,0.0211197810766749,0.408400145787155
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33045,0.00742455883751761,0.00753451103318521,-0.0073430827875254,0.0221922004625606,0.32445200714032
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20023.Mean time to correctly identify matches,51362,0.00580036022581853,0.00442549313509691,-0.00287360631897142,0.0144743267706085,0.189980529658595
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#1.Illnesses of father_Heart disease,48498,-0.00523789547180379,0.00904245922495665,-0.0229611155527188,0.0124853246091112,0.562422121411042
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48073,-0.00116147749419453,0.0195493985317771,-0.0394782986164777,0.0371553436280886,0.952624106378485
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48044,0.0137689223660507,0.0267504849194595,-0.03866202807609,0.0661998728081914,0.606755796487506
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#12.Illnesses of father_Severe depression,48060,-0.00977772466598012,0.0215191820038135,-0.0519553213934546,0.0323998720614943,0.649564914784488
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48064,-0.02114812811293,0.0161461839759902,-0.0527946487058708,0.0104983924800108,0.190279256996349
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#2.Illnesses of father_Stroke,48221,-0.0113273080684453,0.0117293932144372,-0.0343169187687421,0.0116623026318516,0.334194200233294
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48157,-0.00693234340944596,0.0147437880738481,-0.0358301680341882,0.0219654812152962,0.638225459598791
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48068,0.028144899658831,0.0189253333639395,-0.00894875373449032,0.0652385530521523,0.136987291206102
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48215,0.0224250874449528,0.0132968768531907,-0.00363679118730103,0.0484869660772066,0.0917140419641649
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48262,0.00787894876814132,0.0100315253530573,-0.011782840923851,0.0275407384601337,0.432215867359858
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#9.Illnesses of father_Diabetes,48145,0.0187996286208969,0.0140078581071026,-0.00865577326902421,0.0462550305108181,0.17958378820821
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49848,0.00600354961576426,0.0100751027091614,-0.0137436516941921,0.0257507509257206,0.55126087696915
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49719,-0.0164225806766476,0.0146502692842575,-0.0451371084737924,0.0122919471204972,0.262309301276125
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49653,0.0163912275979832,0.0311625643363085,-0.0446873985011816,0.0774698536971479,0.598899106063197
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49691,0.00795664209060541,0.0157611264793498,-0.0229351658089202,0.038848449990131,0.613684762538182
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#2.Illnesses of mother_Stroke,49782,0.013902372672017,0.0115702112076168,-0.00877524129491197,0.036579986638946,0.229542946039084
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49676,0.0196191363758132,0.0214949198469227,-0.0225109065241553,0.0617491792757818,0.361391371697318
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49672,-0.0136951320627249,0.0190095706510115,-0.0509538905387075,0.0235636264132577,0.471264789587856
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49700,-0.000143023941927641,0.0151007682850958,-0.0297405297807154,0.0294544818968601,0.992443181909231
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49712,0.00951328676406833,0.016924675437902,-0.0236590770942196,0.0426856506223563,0.574055826505838
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49871,0.0120633151564328,0.00872477545500644,-0.00503724473537985,0.0291638750482454,0.166784202782106
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49728,0.029276061724135,0.0137286604780464,0.0023678871871642,0.0561842362611059,0.0329772087823378
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46275,-0.00852009534843723,0.0142579749853475,-0.0364657263197184,0.0194255356228439,0.550135088765841
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46134,0.12657207811631,0.0564465640811519,0.0159368125172527,0.237207343715368,0.0249498274375293
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46130,0.0740632558762936,0.0583587060976189,-0.0403198080750395,0.188446319827627,0.204417669479246
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46195,0.00173603856096756,0.0157751312836186,-0.0291832187549249,0.03265529587686,0.912371472914317
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46145,-0.0137334963958312,0.0334457377140979,-0.0792871423154631,0.0518201495238007,0.681355085590402
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46160,0.0267402852834432,0.0242760100622107,-0.0208406944384898,0.0743212650053762,0.270686655071055
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46140,-0.0410775904760835,0.029351874441133,-0.0986072643807043,0.0164520834285372,0.161681053736307
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46139,0.0204662517052919,0.0288219684288725,-0.0360248064152981,0.0769573098258819,0.477654668251745
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46158,0.0184558095484248,0.020985297220957,-0.0226753730046509,0.0595869921015005,0.379159580583361
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46159,0.0292598174437843,0.0252930593066204,-0.0203145787971918,0.0788342136847604,0.247353782938343
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46347,0.00434183782042663,0.0105367964752931,-0.0163102832711478,0.0249939589120011,0.680296317604768
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46230,0.0253182289217226,0.0151393144929158,-0.00435482748439243,0.0549912853278375,0.0944697378357881
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20127.Neuroticism score,45827,0.0113559072299907,0.0180025173520584,-0.0239290267800438,0.0466408412400253,0.528180983083119
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33194,0.0367837792608037,0.0289412945292738,-0.0199411580165728,0.0935087165381803,0.203769959966104
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20161.Pack years of smoking,31693,0.00673651352356635,0.00885229699712678,-0.0106139885908021,0.0240870156379348,0.446687545138819
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31693,0.00654362500664655,0.00873426231976489,-0.0105755291400926,0.0236627791533857,0.453766820613421
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20191.Fluid intelligence score,31334,0.0435006176225093,0.0334213088974411,-0.0220051478164753,0.109006383061494,0.193102514470113
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31334,0.0176218121289351,0.0340121492769129,-0.0490420004538141,0.0842856247116844,0.604402772511328
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20240.Maximum digits remembered correctly,30594,-0.00805064890316988,0.0354354693576508,-0.0775041688441654,0.0614028710378257,0.820282156575853
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20255.Spirometry QC measure,45380,0.0356798169287939,0.0241347227854947,-0.0116242397307756,0.0829838735883635,0.139326403714461
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20261.avMSE,30365,-0.00492434352772544,0.00866462654503908,-0.021907011556002,0.0120583245005512,0.56983434854745
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20262.Myopia diagnosis,30365,0.0300070666464234,0.0429719529966742,-0.054217961227058,0.114232094519905,0.485020674416149
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20280.Glucose-lactate,40000,0.0123679755282175,0.00565679076320882,0.00128066563232821,0.0234552854241068,0.0288016197796923
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20281.Spectrometer-corrected alanine,40037,0.0165318612118945,0.00539995217941327,0.00594795494024446,0.0271157674835445,0.00220618505283139
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33022,-0.0620903146176937,0.0255273032440415,-0.112123828976015,-0.0120568002593723,0.0150231947096236
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33019,-0.0238415557955046,0.0481169994552929,-0.118150874727879,0.0704677631368695,0.62026605345965
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33017,-0.0987784506559941,0.059462986350248,-0.21532590390248,0.0177690025904919,0.0967148225120775
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33017,-0.0660926847713611,0.0240022391792764,-0.113137073562743,-0.0190482959799793,0.00590671436826196
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33017,-0.110486340322976,0.0478027087785264,-0.204179649528888,-0.016793031117064,0.020839980692117
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33024,-0.133349840269105,0.0582855075007826,-0.247589434970639,-0.019110245567571,0.0221691529537636
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33024,-0.0563182498881251,0.0388397812197968,-0.132444221078927,0.0198077213026767,0.147091033513176
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33024,-0.0635263750810844,0.0427694554695085,-0.147354507801321,0.0203017576391523,0.137495555444279
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33024,-0.0528844324584768,0.0701035434918481,-0.190287377702499,0.0845185127855454,0.45064418643326
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33024,-0.109691569712652,0.0854877778044141,-0.277247614209304,0.0578644747839996,0.199482710272707
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33024,-0.0437454479811207,0.0440732515161157,-0.130129020952708,0.0426381249904662,0.3209513202526
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33024,-0.0970203811531602,0.0869936621300553,-0.267527958928069,0.0734871966217482,0.264771125458911
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33024,-0.179285930812774,0.0591525186467549,-0.295224867360413,-0.0633469942651344,0.00244545988912687
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33023,-0.0626276139378983,0.0685658601445808,-0.197016699821277,0.07176147194548,0.361061292281906
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33023,-0.0495174098834431,0.0326860163923107,-0.113582002012372,0.0145471822454859,0.129824038974816
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33023,-0.112096665478407,0.0531233172137147,-0.216218367217288,-0.00797496373952632,0.0348767748533137
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33025,-0.0316411199898257,0.0775551601348436,-0.183649233854119,0.120366993874468,0.68329697743068
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20600.Liking for adding salt to foods,34819,-0.00409527621648677,0.0265511156917254,-0.0561354629722685,0.0479449105392949,0.8774225549105
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20601.Liking for aniseed,34819,0.0244351469603726,0.0263602746442963,-0.0272309913424481,0.0761012852631933,0.353964434040847
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20602.Liking for apple juice,34819,0.0160632742382126,0.0266913877969684,-0.0362518458438455,0.0683783943202708,0.547310543664681
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20603.Liking for apples,34819,-0.00445535192522024,0.0272167610100918,-0.0578002035050002,0.0488894996545597,0.869971432712529
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20604.Liking for asparagus,34819,-0.0335635328412521,0.027307855473407,-0.0870869295691298,0.0199598638866257,0.219069818289318
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20605.Liking for aubergine,34819,-0.0346117241375039,0.0266078866013762,-0.0867631818762012,0.0175397336011934,0.193353475901809
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20606.Liking for avocados,34819,-0.0348801688093137,0.027475401628254,-0.0887319560006916,0.0189716183820641,0.204289412611951
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20607.Liking for bacon,34819,0.0157339417298031,0.0269104695382617,-0.0370105785651898,0.0684784620247961,0.558777428442352
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20608.Liking for baked or steamed fish,34819,-0.0782164491381624,0.0274259312648504,-0.131971274417269,-0.0244616238590557,0.00435425853632234
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20609.Liking for bananas,34819,0.029519450601943,0.0277740853458388,-0.0249177566759011,0.0839566578797871,0.287878613037955
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34819,-0.0453135519812349,0.0266743925486279,-0.0975953613765456,0.00696825741407574,0.089393307395815
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20611.Liking for beef steak,34819,-0.0759195040622984,0.0268487828905044,-0.128543118527687,-0.0232958895969099,0.00469780337842911
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20612.Liking for beetroot,34819,0.0235942017376258,0.0274403633771915,-0.0301889104816695,0.0773773139569211,0.389899563353964
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20613.Liking for bell pepper,34819,-0.0852421325742346,0.0268777547573492,-0.137922531898639,-0.0325617332498302,0.00152109194998692
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20614.Liking for bicycling,34819,-0.0584169738658639,0.0267860852044424,-0.110917700866571,-0.00591624686515681,0.0292154405622101
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20615.Liking for biscuits,34819,0.0400681117194822,0.0265181571818744,-0.0119074763569917,0.0920436997959561,0.130826870923248
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20616.Liking for bitter foods,34819,-0.0549377593463783,0.0265555880093482,-0.106986711844701,-0.00288880684805596,0.0385911698136141
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20617.Liking for bitter or ale,34819,-0.0428978226565961,0.0276049742107023,-0.0970035721095726,0.0112079267963804,0.120217623456983
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20618.Liking for black olives,34819,-0.0644742392009598,0.0268941714820399,-0.117186815305758,-0.0117616630961615,0.0165325850623734
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20619.Liking for black pepper,34819,-0.0226301599247725,0.0269092211330701,-0.0753722333455898,0.0301119134960448,0.400377654165062
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20620.Liking for blue cheese,34819,-0.0762549358536509,0.0269376618900623,-0.129052753158173,-0.0234571185491287,0.00465222460201568
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20621.Liking for bolognese sauce,34819,-0.0379185891024586,0.0270820455529049,-0.0909993983861521,0.015162220181235,0.161502081924507
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20622.Liking for broad beans,34819,-0.0101838742401552,0.0266633203720324,-0.0624439821693386,0.0420762336890283,0.702511322105049
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20623.Liking for broccoli,34819,-0.0202430671521417,0.0281741980791219,-0.0754644953872206,0.0349783610829372,0.472467314474368
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20624.Liking for brown rice,34819,0.00195111928283787,0.0268554013055418,-0.0506854672760241,0.0545877058416998,0.942083836374316
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20625.Liking for brussel sprouts,34819,-0.0269609752256294,0.0272392359078552,-0.0803498776050255,0.0264279271537668,0.322302551770413
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20626.Liking for burgers (meat),34819,-0.0384079736674592,0.0266236946245084,-0.0905904151314956,0.0137744677965772,0.149156732034748
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20627.Liking for burn of spicy foods,34819,-0.0440633737636553,0.0265346458185612,-0.0960712795680352,0.00794453204072466,0.0968245236729409
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20628.Liking for butter on bread,34819,-0.0103588554410364,0.0271894367544942,-0.0636501514798451,0.0429324405977723,0.703219794276993
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20629.Liking for butternut squash,34819,0.0111210668083304,0.0269729753600301,-0.0417459648973286,0.0639880985139895,0.680125117916001
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20630.Liking for cabbage,34819,-0.0261466624806673,0.0270021928114136,-0.0790709603910379,0.0267776354297034,0.332909053112007
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20631.Liking for cake,34819,0.0574730255839107,0.0266698036355769,0.00520021045818002,0.109745840709641,0.0311859861376807
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20632.Liking for cake icing,34819,0.00193611842091435,0.0264579608974744,-0.0499214849381354,0.0537937217799641,0.941666554803819
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20633.Liking for capers,34819,-0.0435651633342117,0.0266380804235023,-0.0957758009642762,0.00864547429585281,0.1019858036289
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20634.Liking for cauliflower,34819,-0.0218510643702023,0.027465176698337,-0.0756828106989428,0.0319806819585382,0.426287671260791
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20635.Liking for cereal or granola bar,34819,0.0330374344497636,0.0266156849582684,-0.0191293080684425,0.0852041769679696,0.214531591126492
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20636.Liking for cheesecake,34819,-0.00911800317518147,0.0266133833606961,-0.0612802345621459,0.0430442282117829,0.731899058973788
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20637.Liking for cherries,34819,-0.0206277072358452,0.0290891967247681,-0.0776425328163907,0.0363871183447003,0.478266483721098
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20638.Liking for chicken,34819,-0.037626013566438,0.0284681725689059,-0.0934236318014936,0.0181716046686176,0.186301589621999
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20639.Liking for chilli pepper,34819,-0.0604429377766557,0.0266590460878853,-0.112694668108911,-0.00819120744440059,0.0233949818864509
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20640.Liking for chips or french fries,34819,0.00844198359431516,0.0267409524390035,-0.0439702831861318,0.0608542503747621,0.752240421931353
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20641.Liking for cigarette smoking,34819,-0.00992906361477857,0.0442566226744935,-0.0966720440567858,0.0768139168272287,0.822487810527659
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20642.Liking for cod,34819,-0.0723157712478463,0.0275156112094695,-0.126246369218406,-0.0183851732772862,0.00859716110513278
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20643.Liking for coffee with sugar,34819,0.0689527253674708,0.0302947416399628,0.00957503175314359,0.128330418981798,0.0228625900854187
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20644.Liking for coffee without sugar,34819,-0.0643065278428552,0.0275516355204795,-0.118307733462995,-0.0103053222227154,0.0196128221603957
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20645.Liking for coriander,34819,-0.0282764750728053,0.0266562259562029,-0.0805226779469629,0.0239697278013524,0.288813199484635
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20646.Liking for corn flakes,34819,0.0555389068011161,0.0267355411953615,0.00313724605820767,0.107940567544025,0.0377944341544573
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20647.Liking for cream,34819,-0.0148607403579866,0.0266798682218642,-0.0671532820728405,0.0374318013568673,0.577538087299333
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20648.Liking for croissant,34819,-0.00153925913819754,0.026694757081181,-0.0538609830173124,0.0507824647409173,0.954019391270594
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20649.Liking for cucumber,34819,0.00519257351073669,0.0269958740450316,-0.0477193396175253,0.0581044866389987,0.847474230120773
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20650.Liking for curry,34819,-0.0170392872551959,0.0267703583319494,-0.0695091895858167,0.0354306150754248,0.524465761218485
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20651.Liking for dairy products,34819,0.0144805177800466,0.0271093696529112,-0.0386538467396594,0.0676148822997525,0.593247998069519
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20652.Liking for dark chocolate,34819,-0.00402943904069097,0.0269581252202424,-0.056867364472366,0.0488084863909841,0.88118545396717
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20653.Liking for diet fizzy drinks,34819,-0.00501664934517851,0.02776707375426,-0.0594401139035282,0.0494068152131712,0.856630930274138
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20654.Liking for dried fruit,34819,-0.0311200108711739,0.0266775647188756,-0.0834080377201701,0.0211680159778224,0.24342963837826
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20655.Liking for eggs,34819,-0.0325204769874833,0.0278900536863903,-0.0871849822128082,0.0221440282378417,0.243631516823062
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20656.Liking for exercising alone,34819,-0.0291513531895432,0.0266144515349812,-0.0813156781981064,0.02301297181902,0.273401736241752
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20657.Liking for exercising with others,34819,-0.0302677470982004,0.026515639392565,-0.0822384003076278,0.0217029061112271,0.253686030742092
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20658.Liking for extra virgin olive oil,34819,-0.0372096331922351,0.0271372291837618,-0.0903986023924083,0.0159793360079381,0.170353066657949
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20659.Liking for fatty foods,34819,-0.00978164149664878,0.0266411158196288,-0.0619982285031213,0.0424349455098237,0.713504671677069
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20660.Liking for fresh tomatoes,34819,0.0145656878743806,0.0295943912587179,-0.0434393189927065,0.0725706947414677,0.622604434296077
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20661.Liking for fried chicken,34819,0.00775489251150815,0.0267631694315799,-0.0447009195743885,0.0602107045974048,0.772005749854569
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20662.Liking for fried or battered fish,34819,-0.0257246702650877,0.0267781518902367,-0.0782098479699516,0.0267605074397762,0.336746120845196
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20663.Liking for fruit,34819,-0.0143023974458347,0.031019554177613,-0.0751007236339562,0.0464959287422868,0.644753171496354
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20664.Liking for garlic,34819,-0.050251393836002,0.0272344971898477,-0.103631008328103,0.00312822065609944,0.0650460568103213
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20665.Liking for gherkins,34819,-0.0316458994316493,0.0267598836467126,-0.084095271379206,0.0208034725159074,0.236999879825078
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20666.Liking for globe artichoke,34819,-0.0330485396060938,0.0269313419991386,-0.0858339699244056,0.0197368907122179,0.219797690436488
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20667.Liking for goat's cheese,34819,-0.0755584077000388,0.0264862300103298,-0.127471418520285,-0.0236453968797923,0.00434295114520753
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20668.Liking for going to a cafe,34819,0.0447079421880422,0.0270671584399276,-0.00834368835421585,0.0977595727303002,0.0986176212884524
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20669.Liking for going to the gym,34819,-0.0320668669423173,0.0263745605932688,-0.0837610057051241,0.0196272718204894,0.224079058820427
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20670.Liking for going to the pub,34819,-0.0299918510568908,0.0265031665038529,-0.0819380574044424,0.0219543552906609,0.257815065641384
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20671.Liking for grapefruit,34819,-0.0249785617034796,0.026584261166137,-0.0770837135891081,0.0271265901821488,0.347444881103388
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20672.Liking for green olives,34819,-0.0669857705879966,0.0271883161646824,-0.120274870270774,-0.0136966709052191,0.0137645411447528
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20673.Liking for haddock,34819,-0.0571892683748343,0.0275774730739597,-0.111241115599795,-0.00313742114987317,0.0381255583448984
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20674.Liking for ham,34819,-0.0102308986150883,0.0268796262355185,-0.0629149660367045,0.0424531688065279,0.703493726415904
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20675.Liking for hard cheese,34819,-0.0244605769770863,0.0275658927276462,-0.0784897267232728,0.0295685727691002,0.374911447048301
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20676.Liking for herring,34819,-0.0213802897335686,0.0265641819875909,-0.0734460864292467,0.0306855069621096,0.420922374553806
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20677.Liking for honey,34819,0.000218744236072697,0.0267664822148469,-0.0522435609050271,0.0526810493771725,0.993479662661639
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20678.Liking for horseradish or wasabi,34819,-0.0258379047379764,0.0267094047059156,-0.078188337961571,0.0265125284856182,0.333381165604255
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20679.Liking for ice cream,34819,0.0190698355052031,0.0266248798643138,-0.033114929028852,0.0712546000392581,0.473858583668642
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20680.Liking for jam,34819,0.0292050761054089,0.0265997253699543,-0.0229303856197015,0.0813405378305193,0.272253361135977
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20681.Liking for kiwi fruit,34819,-0.015937750669094,0.0266705552162139,-0.0682120388928733,0.0363365375546852,0.550134269894361
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20682.Liking for lager,34819,-0.0288807933586593,0.0268741190856526,-0.0815540667665384,0.0237924800492198,0.282547802578198
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20683.Liking for lamb,34819,-0.0445240004868926,0.02716472512838,-0.0977668617385175,0.00871886076473225,0.101235840419735
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20684.Liking for lemons,34819,-0.0162207970896979,0.0268534766711791,-0.0688536113652089,0.0364120171858131,0.5458247557528
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20685.Liking for lentils or beans,34819,0.00635020509182212,0.0270445402130741,-0.0466570937258032,0.0593575039094474,0.814364388673846
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20686.Liking for liver,34819,-0.0822215619435906,0.0270015502615142,-0.135144600456159,-0.0292985234310228,0.00233211922721404
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20687.Liking for mackerel,34819,-0.0230066333487102,0.0268586007371452,-0.0756494907935147,0.0296362240960944,0.391694941924344
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20688.Liking for marzipan,34819,-0.0200683640579846,0.0266010320287331,-0.0722063868343015,0.0320696587183323,0.450613912710941
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20689.Liking for mayonnaise,34819,-0.0251068814829079,0.0267483540191645,-0.0775336553604703,0.0273198923946545,0.347941210855548
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20690.Liking for melon,34819,0.0471898085084265,0.0280655170589632,-0.00781860492714126,0.102198221943994,0.0927122932130196
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20691.Liking for milk chocolate,34819,0.0175138441651114,0.0270160766156971,-0.0354376660016548,0.0704653543318777,0.51682154038442
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20692.Liking for mushrooms,34819,-0.045426050770297,0.0278336912665317,-0.0999800856526991,0.00912798411210505,0.102698784695983
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20694.Liking for orange juice,34819,0.0402948554862542,0.0268104263233061,-0.0122535801074258,0.0928432910799343,0.132881219361015
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20695.Liking for oranges,34819,0.010268370337822,0.0273320825297855,-0.0433025114205575,0.0638392520962014,0.707155603650458
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20696.Liking for pasta,34819,-0.0407853300247449,0.0270212699785569,-0.0937470191827164,0.0121763591332266,0.131232528391461
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20697.Liking for pears,34819,-0.00225291205951232,0.0275437905111272,-0.0562387414613217,0.051732917342297,0.934812244672079
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20698.Liking for pizza,34819,0.0156766391000824,0.0268451089865652,-0.0369397745135855,0.0682930527137502,0.559255698554316
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20699.Liking for plain yogurt,34819,-0.0451985685126835,0.0270145931475747,-0.09814717108193,0.00775003405656296,0.0943345104572672
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20700.Liking for plums,34819,-0.0157094102743439,0.0275174864909029,-0.0696436837965137,0.0382248632478259,0.568087767238051
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20701.Liking for pollock,34819,-0.0316266652643057,0.0266342623862314,-0.0838298195413192,0.0205764890127077,0.235080204020883
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20702.Liking for pork chop,34819,-0.00256514673077127,0.0267067130009302,-0.0549103042125944,0.0497800107510519,0.923483702907887
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20703.Liking for porridge,34819,0.00534733575424281,0.027551771576616,-0.0486541365359246,0.0593488080444102,0.846114548732534
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20704.Liking for potato crisps,34819,0.00584007536534822,0.0268228052788134,-0.046732622981126,0.0584127737118224,0.827645346045108
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20705.Liking for potatoes,34819,0.0345372218671749,0.0270388016391293,-0.0184588293455185,0.0875332730798683,0.201517664658555
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20706.Liking for prawns,34819,-0.0589503762233139,0.0273463673363652,-0.11254925620259,-0.00535149624403819,0.0311305943874739
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20707.Liking for raw carrots,34819,-0.0371044356197786,0.0272177252729569,-0.090451177154774,0.0162423059152169,0.172834850593893
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20708.Liking for red meat,34819,-0.0699152293335067,0.0268137617710076,-0.122470202404682,-0.0173602562623317,0.00913533214292238
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20709.Liking for red wine,34819,-0.0462590183727553,0.0266287614088996,-0.0984513907341986,0.00593335398868797,0.0823846880840069
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34819,0.0171981314466052,0.0282322406525312,-0.0381370602323559,0.0725333231255664,0.542427531795581
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20711.Liking for roast chicken,34819,-0.0205488641836204,0.0286668666335407,-0.0767359227853603,0.0356381944181195,0.47350389682731
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20712.Liking for salad dressing,34819,0.0133790968627108,0.0266547220957786,-0.0388641584450153,0.0656223521704368,0.615719719172464
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20713.Liking for salad leaves,34819,0.00936628907613789,0.0277033100428881,-0.0449321986079228,0.0636647767601985,0.735300124110912
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20714.Liking for salami,34819,-0.00669527042259501,0.0267248465869205,-0.0590759697329591,0.0456854288877691,0.802185525837183
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20715.Liking for salmon,34819,-0.0684397624776894,0.0286284171723661,-0.124551460135527,-0.0123280648198518,0.0168375495523912
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20716.Liking for salty foods,34819,-0.00304832413427775,0.0265505553722505,-0.0550874126638888,0.0489907643953333,0.908596309882796
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20717.Liking for salty pretzels,34819,0.0170732125877231,0.0267558408891933,-0.0353682355550958,0.069514660730542,0.523415139085578
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20718.Liking for sardines,34819,-0.0354507122723785,0.026739983802466,-0.087861080525212,0.0169596559804549,0.184949541498595
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20719.Liking for sausages (meat),34819,-0.0269464526869083,0.0266114527531475,-0.0791049000830774,0.0252119947092609,0.311280377658852
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20720.Liking for savoury biscuits,34819,0.0230812493682176,0.0269355017590128,-0.0297123340794475,0.0758748328158828,0.391515505846803
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34819,-0.0738376122868738,0.0267681829754356,-0.126303250918728,-0.0213719736550201,0.00581852660905847
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20722.Liking for skimmed milk,34819,0.0194860094233022,0.0266701075384483,-0.0327874013520565,0.0717594201986609,0.465021049316243
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20723.Liking for smoked fish,34819,-0.0594619221014217,0.0269578686209123,-0.11229934459841,-0.00662449960443356,0.027424417803289
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20724.Liking for soft cheese,34819,-0.0571028175238791,0.0267584010319685,-0.109549283546537,-0.00465635150122078,0.0328650067219147
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20725.Liking for soy sauce,34819,-0.00930302734612874,0.0270664199653779,-0.0623532104782695,0.043747155786012,0.731070584458018
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20726.Liking for soya milk,34819,0.0216967972909965,0.0269016612396182,-0.0310304587386551,0.0744240533206482,0.419960109535527
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20727.Liking for spicy foods,34819,-0.0333957462127855,0.0265745468604577,-0.0854818580592826,0.0186903656337117,0.208897263082123
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20728.Liking for spinach,34819,-0.0328357745874552,0.0271956349852725,-0.0861392191585892,0.0204676699836788,0.227309032697048
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20729.Liking for spirits,34819,-0.0513603345074342,0.0263757067192904,-0.103056719677243,0.00033605066237502,0.0515306687453451
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20730.Liking for strawberries,34819,0.0398197673205674,0.0305665745091568,-0.0200907187173799,0.0997302533585148,0.192698446150511
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34819,0.0173149878659621,0.0278701401981365,-0.0373104869223855,0.0719404626543097,0.534433161852385
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20732.Liking for sweet foods,34819,0.0359475758776002,0.0265805257185908,-0.0161502545308378,0.0880454062860381,0.176276036290239
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20733.Liking for taking the stairs,34819,-0.0243579596280235,0.0274668480611523,-0.078192981827882,0.029477062571835,0.375200143394472
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20734.Liking for tea with sugar,34819,0.0625529123497969,0.0357032556628912,-0.0074254687494698,0.132531293449064,0.0797995043908417
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20735.Liking for tea without sugar,34819,0.00145894912269789,0.0286943928007668,-0.0547820607668051,0.0576999590122009,0.959450492661568
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20736.Liking for tomato ketchup,34819,0.0210232230357203,0.0265368514093069,-0.0309890057265212,0.0730354517979618,0.428246188729939
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20737.Liking for tinned tuna,34819,-0.0426079453923497,0.0271552511165999,-0.0958322375808854,0.010616346796186,0.116666846591151
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20738.Liking for turnip (white),34819,0.0213748895629419,0.0266695386857122,-0.030897406261054,0.0736471853869379,0.422876809715115
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20739.Liking for vegetables,34819,-0.0423412464537123,0.0311173582724332,-0.103331268667681,0.0186487757602568,0.173639572986588
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20740.Liking for vinegar,34819,0.0215439302092876,0.0266780851935795,-0.0307451167701282,0.0738329771887035,0.419367306331836
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20741.Liking for watching television,34819,0.0437816575650501,0.0269443329000993,-0.00902923491914459,0.0965925500492448,0.104215787745044
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20742.Liking for whisky,34819,-0.019684918038676,0.0284780510833419,-0.0755018981620262,0.0361320620846742,0.489435737357867
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20743.Liking for white bread,34819,-0.0168066350638604,0.0264196782703074,-0.0685892044736629,0.0349759343459422,0.524698715481619
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20744.Liking for white rice,34819,-0.0595929173828996,0.0268774475031038,-0.112272714488983,-0.00691312027681611,0.0266304422919196
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20745.Liking for white wine,34819,-0.0174170179741912,0.0267302947845984,-0.0698083957520041,0.0349743598036217,0.514684376568523
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34819,-0.011541528549019,0.0269372255800426,-0.0643384906859026,0.0412554335878646,0.668325027108649
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20747.Liking for whole milk,34819,0.0260700560737453,0.0266645102639548,-0.0261923840436061,0.0783324961910966,0.328242505515087
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20748.Liking for wholemeal bread,34819,0.0149204037511066,0.0282420863416133,-0.0404340854784555,0.0702748929806688,0.597299758393036
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20749.Liking for working up a sweat,34819,-0.0483586085640588,0.0268348397263031,-0.100954894427613,0.00423767729949537,0.0715614097537866
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21001.Body mass index (BMI),51567,-0.110374351766176,0.0157553775187412,-0.141254891702909,-0.0794938118294434,2.51844358819652e-12
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21002.Weight,51575,0.00858187680908824,0.00974382100930304,-0.0105160123691457,0.0276797659873222,0.378460593094684
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21021.Pulse wave Arterial Stiffness index,33421,0.0103848136405534,0.00700232289747111,-0.00333973923848995,0.0241093665195968,0.138095554784955
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34228,-0.012740469780345,0.0279799917077907,-0.0675812535276147,0.0421003139669247,0.648873219440718
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34243,0.00266377597365754,0.0292081293970602,-0.0545841576445804,0.0599117095918955,0.927335688831747
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34244,0.00643240496526511,0.0294601524021492,-0.0513094937429473,0.0641743036734775,0.827166771038352
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21040.Satisfaction with bowel habits,34195,0.0178272895004284,0.0272534064346837,-0.0355893871115517,0.0712439661124085,0.513043065304985
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34178,0.0219628701423645,0.028609624849712,-0.034111994563071,0.0780377348478,0.442699436205759
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21042.Greatest number of times bowels opened per day,34191,0.031490208812764,0.0291446580185776,-0.0256333209036481,0.0886137385291761,0.279955418672763
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21043.Least number of times bowels opened per week,34102,0.0379396070953931,0.0289880106550936,-0.0188768937885903,0.0947561079793765,0.190632122881496
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21044.Average number of times bowels opened per day,34153,0.0600204969549977,0.0334656063421198,-0.00557209147555705,0.125613085385552,0.0729244961749517
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34247,-0.0125611946549575,0.029707368233755,-0.0707876363931173,0.0456652470832022,0.672427889701618
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34242,0.0185328369382115,0.0298852429201034,-0.0400422391851912,0.0771079130616143,0.535184407582594
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34244,-0.0509422230975468,0.0347437044493254,-0.119039883818225,0.017155437623131,0.142618059339391
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34244,0.0647558330822435,0.0309892197742561,0.00401696232470152,0.125494703839785,0.0366772867616799
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34241,-0.00325260231391002,0.0463056644755033,-0.0940117046858964,0.0875065000580764,0.94400248359266
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34242,0.0434432274545684,0.0339661103068165,-0.0231303487467919,0.110016803655929,0.200921440161114
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34242,0.0453132311197607,0.0859489484966574,-0.123146707933688,0.213773170173209,0.598059017940751
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34246,0.0334742380650984,0.0322273203140584,-0.0296913097504562,0.0966397858806529,0.298973961037014
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34245,-0.0605259423538413,0.0341637960685375,-0.127486982648175,0.00643509794049221,0.0764854560888962
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,33989,0.028550716116533,0.0301998365552165,-0.0306409635316914,0.0877423957647573,0.344482195851998
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34243,-0.000540781343407165,0.0304729650753858,-0.0602677928911633,0.059186230204349,0.985841633167308
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34244,-0.0682456648634185,0.0404844181947229,-0.147595124525075,0.0111037947982383,0.0918803146028606
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34246,-0.0415581407412627,0.0297389507536822,-0.0998464842184797,0.0167302027359543,0.162315568128229
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34244,-0.0216044233108653,0.0295930890679827,-0.0796068778841113,0.0363980312623807,0.46537732328634
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X21100.Water hardness (USGS classification),51433,0.00280455191711698,0.0175215229234581,-0.031537633012861,0.0371467368470949,0.87283244783939
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2139.Age first had sexual intercourse,47817,0.00141680178865949,0.00495045459611841,-0.00828608921973258,0.0111196927970516,0.774730314812521
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2149.Lifetime number of sexual partners,46318,-0.0305020753326396,0.0197571451025066,-0.0692260797335525,0.00822192906827326,0.122639063113799
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22032.IPAQ activity group,45413,-0.0302836464587357,0.0197436693889525,-0.0689812384610826,0.00841394554361121,0.125083905995039
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22033.Summed days activity,46086,-0.0119085468865308,0.00471140894573376,-0.021142908420169,-0.00267418535289265,0.0114916427738816
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22034.Summed minutes activity,45413,-0.0102091488753872,0.00474234216108721,-0.0195041395111181,-0.000914158239656238,0.0313485171701059
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22037.MET minutes per week for walking,44384,-0.002294789036965,0.00480999545204216,-0.0117223801229676,0.00713280204903764,0.633304996958891
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22038.MET minutes per week for moderate activity,45413,-0.0133475741222024,0.00467815289062852,-0.0225167537878343,-0.0041783944565705,0.00433275880009188
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22039.MET minutes per week for vigorous activity,45413,-0.0627037535056824,0.0196771418671971,-0.101270951565389,-0.0241365554459761,0.00144152279765814
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22040.Summed MET minutes per week for all activity,44384,-0.00858082573273013,0.00490877852228464,-0.018202031636408,0.00104038017094776,0.0804695161094233
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X2217.Age started wearing glasses or contact lenses,47848,-0.00674623336962559,0.00451610912559797,-0.0155978072557976,0.00210534051654643,0.135237360383754
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X22501.Year ended full time education,31214,0.0016138141525819,0.0206999519860586,-0.038958091740093,0.0421857200452568,0.937860414501729
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X22506.Tobacco smoking,31171,0.0145294251722837,0.0756040404170431,-0.133654494045121,0.162713344389688,0.847608671535953
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49818,-0.00156979943133096,0.0410437573053457,-0.0820155637498085,0.0788759648871466,0.969491071124969
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23098.Weight,51165,0.0115077891196783,0.00981131532073387,-0.00772238890896008,0.0307379671483167,0.240842387676399
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23099.Body fat percentage,51166,-0.00754300714274739,0.0100513911320968,-0.027243733761657,0.0121577194761623,0.452993890321708
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23100.Whole body fat mass,51157,-0.00837664728081438,0.00964186754629538,-0.0272747076715533,0.0105214131099246,0.384976099380003
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23101.Whole body fat-free mass,51165,0.00916251864753455,0.0080638680960879,-0.00664266282079773,0.0249677001158668,0.255864814188955
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23102.Whole body water mass,51165,0.00865819063497968,0.00809243621505462,-0.00720298434652738,0.0245193656164867,0.284668809725962
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23104.Body mass index (BMI),51165,-0.105825420717143,0.0159369220703265,-0.137061787974983,-0.0745890534593032,3.19118555383841e-11
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23105.Basal metabolic rate,51163,0.00925400913276775,0.00879615775590371,-0.00798646006880353,0.026494478334339,0.292785534657344
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23106.Impedance of whole body,51160,0.00681531519677792,0.0065921167322518,-0.0061052335984356,0.0197358639919914,0.301211730587872
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23107.Impedance of leg (right),51162,-0.0101945120039287,0.00539286979895088,-0.0207645368098724,0.000375512802015027,0.0587194882353902
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23108.Impedance of leg (left),51161,-0.00737246007044614,0.00533698406543657,-0.0178329488387018,0.00308802869780953,0.16717042433618
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23109.Impedance of arm (right),51153,0.0145649726725281,0.0065988284471231,0.00163126891616686,0.0274986764288894,0.0273081561789711
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23110.Impedance of arm (left),51160,0.0184095686343819,0.00661638383718501,0.00544145631349931,0.0313776809552645,0.00539927790289026
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23111.Leg fat percentage (right),51161,-0.0308006299453868,0.0158699676815691,-0.0619057666012623,0.00030450671048866,0.0522915446890277
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23112.Leg fat mass (right),51160,-0.0283391191744672,0.0182116122053384,-0.0640338790969306,0.00735564074799607,0.119695779680024
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23113.Leg fat-free mass (right),51160,0.0222562941961956,0.00820077016312244,0.00618278467647557,0.0383298037159155,0.00665334110058406
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23114.Leg predicted mass (right),51159,0.0226940168708666,0.00823123251949759,0.00656080113265137,0.0388272326090819,0.00583629267641868
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23115.Leg fat percentage (left),51156,-0.0209110504865786,0.0163658911855578,-0.0529881972102719,0.0111660962371147,0.201358760710862
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23116.Leg fat mass (left),51156,-0.0289961906970161,0.0182746124894635,-0.0648144311763645,0.00682204978233238,0.11259414431581
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23117.Leg fat-free mass (left),51154,0.0197742750287364,0.00841091762880817,0.00328887647627236,0.0362596735812004,0.0187290210228451
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23118.Leg predicted mass (left),51153,0.0195495392472391,0.00844328515923875,0.00300070033513118,0.0360983781593471,0.0205988717288994
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23119.Arm fat percentage (right),51153,-0.0215397599210009,0.0111768680580789,-0.0434464213148354,0.000366901472833726,0.0539686530761991
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23120.Arm fat mass (right),51149,-0.0356517054478295,0.0100651427205598,-0.0553793851801267,-0.0159240257155324,0.000397637000774826
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23121.Arm fat-free mass (right),51151,0.00200555189901262,0.00784382458315492,-0.013368344283971,0.0173794480819963,0.79819569275422
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23122.Arm predicted mass (right),51150,0.00116479008775664,0.00784158643744519,-0.0142047193296359,0.0165342995051492,0.881917658108715
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23123.Arm fat percentage (left),51148,-0.0148210603378626,0.0125213692650276,-0.0393629440973167,0.00972082342159154,0.236557700104677
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23124.Arm fat mass (left),51147,-0.0281697476379145,0.0103148943402532,-0.0483869405448109,-0.00795255473101817,0.00631881767209467
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23125.Arm fat-free mass (left),51147,-0.00422032879487673,0.00845762520315798,-0.0207972741930664,0.0123566166033129,0.617785676710717
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23126.Arm predicted mass (left),51145,-0.00413623730543206,0.00846548515425868,-0.0207285882077791,0.012456113596915,0.625128821651408
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23127.Trunk fat percentage,51143,-0.00222049994210965,0.00635436803676715,-0.0146750612941733,0.010234061409954,0.726758271174337
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23128.Trunk fat mass,51139,0.004215691015702,0.0073284470328073,-0.0101480651686003,0.0185794472000043,0.565126909873267
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23129.Trunk fat-free mass,51133,0.00355802326746842,0.00753492364488031,-0.011210427076497,0.0183264736114338,0.636784840089845
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23130.Trunk predicted mass,51130,0.00344742864446513,0.00754361786649656,-0.0113380623738681,0.0182329196627984,0.647675216293705
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23400.Total Cholesterol,40044,-0.0564327854470952,0.00560544871501927,-0.067419464928533,-0.0454461059656574,9.09184427131135e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40044,-0.0413966761851957,0.00543632185425249,-0.0520518670195305,-0.0307414853508608,2.79136900910394e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40044,-0.029342220085318,0.00543438562352658,-0.0399936159074301,-0.018690824263206,6.78569211374461e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23403.VLDL Cholesterol,40044,-0.0110225320017559,0.00533701105170195,-0.0214830736630918,-0.000561990340420133,0.0389110575997947
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23404.Clinical LDL Cholesterol,40044,-0.0491514414380278,0.00543321881282494,-0.0598005503111646,-0.0385023325648909,1.64774356845745e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23405.LDL Cholesterol,40044,-0.0511869595144933,0.00543249430105061,-0.0618346483445525,-0.0405392706844341,5.01616235607218e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23406.HDL Cholesterol,40044,-0.0617663558834471,0.00624933226565558,-0.0740150471241321,-0.0495176646427622,5.72463393522854e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23407.Total Triglycerides,40044,0.000861030780159224,0.00577674801333372,-0.0104613953259749,0.0121834568862933,0.88151522060321
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23408.Triglycerides in VLDL,40044,0.000970000355782259,0.00578113438322,-0.0103610230353289,0.0123010237468935,0.866752868099884
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23409.Triglycerides in LDL,40044,-0.0100439534063021,0.00575209349736723,-0.0213180566611419,0.00123014984853763,0.0808065366119622
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23410.Triglycerides in HDL,40044,0.00675843796328709,0.0054403320797977,-0.00390461291311641,0.0174214888396906,0.214150448858143
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40044,-0.0563898686050197,0.00571423926776788,-0.0675897775698448,-0.0451899596401947,6.66654851171292e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23412.Phospholipids in VLDL,40044,-0.00589950750294333,0.00549729965945279,-0.0166742148354708,0.00487519982958414,0.283213870010433
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23413.Phospholipids in LDL,40044,-0.0487772813949029,0.00539427800903529,-0.0593500662926121,-0.0382044964971938,1.70974169901236e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23414.Phospholipids in HDL,40044,-0.0525238286679041,0.00607339152260819,-0.0644276760522162,-0.0406199812835921,5.73534365759961e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23415.Total Esterified Cholesterol,40044,-0.0598555007917165,0.00562043352688407,-0.0708715505044093,-0.0488394510790237,2.15735061275163e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40044,-0.0117663316257574,0.00530445297720714,-0.0221630594610834,-0.00136960379043139,0.0265556273198951
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40044,-0.0498444565534287,0.00542351640266505,-0.0604745487026522,-0.0392143644042052,4.39684295029418e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40044,-0.0629858472892816,0.00620647277998045,-0.0751505339380433,-0.0508211606405199,4.00246954646454e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23419.Total Free Cholesterol,40044,-0.0468532378799597,0.00556580563740111,-0.0577622169292659,-0.0359442588306535,4.15728867658017e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23420.Free Cholesterol in VLDL,40044,-0.00994608115679689,0.00543327334869999,-0.0205952969202489,0.000703134606655085,0.067181242824041
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23421.Free Cholesterol in LDL,40044,-0.0532016899086976,0.00547328702485749,-0.0639293324774183,-0.042474047339977,2.85918990908066e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23422.Free Cholesterol in HDL,40044,-0.0536482172962808,0.0062811411068944,-0.0659592538657938,-0.0413371807267678,1.45018101086921e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40044,-0.0472159927109305,0.00559410783791585,-0.0581804440732456,-0.0362515413486154,3.44027331734179e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23424.Total Lipids in VLDL,40044,-0.00433521015059018,0.00560952415803128,-0.0153298775003315,0.00665945719915112,0.43963454290146
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23425.Total Lipids in LDL,40044,-0.0492355433720727,0.00542386994874706,-0.059866328471617,-0.0386047582725285,1.24076740370221e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23426.Total Lipids in HDL,40044,-0.0558844276682231,0.00614282737617787,-0.0679243693255318,-0.0438444860109145,1.03389048978451e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40044,-0.0770095190496415,0.00572862803515185,-0.0882376299985391,-0.0657814081007439,5.72885810608919e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23428.Concentration of VLDL Particles,40044,-0.0100875551429281,0.00541652984470059,-0.0207039536385413,0.000528843352685061,0.062570466253388
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23429.Concentration of LDL Particles,40044,-0.0325166097355409,0.0053920141766208,-0.0430849575217177,-0.0219482619493641,1.67130149590862e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23430.Concentration of HDL Particles,40044,-0.0748849009415699,0.0057432166717957,-0.0861416056182894,-0.0636281962648503,1.17175611926082e-38
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40044,0.000404442564569499,0.00609358755972601,-0.0115389890524935,0.0123478741816325,0.947082647192867
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23432.Average Diameter for LDL Particles,40044,-0.0187272116058584,0.00556806960265898,-0.02964062802707,-0.00781379518464681,0.000771958192296158
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23433.Average Diameter for HDL Particles,40044,-0.0020377898816184,0.00658502596562813,-0.0149444407742495,0.0108688610110127,0.756977185712679
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23434.Phosphoglycerides,40030,-0.0553041625056349,0.00574516066169848,-0.0665646774025639,-0.0440436476087059,7.1296127058896e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40030,0.0275483576033864,0.00610445198911052,0.0155836317047298,0.0395130835020431,6.44362908626901e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23436.Total Cholines,40030,-0.0578860726923393,0.00575463152777892,-0.069165150486786,-0.0466069948978926,9.90262688666736e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23437.Phosphatidylcholines,40030,-0.0566069677003854,0.0057620797511271,-0.0679006440125945,-0.0453132913881763,1.03261010360978e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23438.Sphingomyelins,40029,-0.0573556411813374,0.00578339589502184,-0.0686910971355802,-0.0460201852270945,4.09935138483136e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23439.Apolipoprotein B,40044,-0.0302970007734423,0.00539050420002187,-0.0408623890054851,-0.0197316125413994,1.93734061512573e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23440.Apolipoprotein A1,40044,-0.061242975520606,0.00595115238512815,-0.0729072341954571,-0.0495787168457548,9.29026481084163e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40044,0.00398238964535481,0.00544774363417645,-0.00669518787763104,0.0146599671683407,0.464780153573258
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23442.Total Fatty Acids,40030,-0.0339579539599729,0.00577464332677665,-0.0452762548804551,-0.0226396530394907,4.17328118913922e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23443.Degree of Unsaturation,40030,-0.0428796644653609,0.00604536604002452,-0.054728581903809,-0.0310307470269129,1.36901851382054e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23444.Omega-3 Fatty Acids,40030,-0.044583844824219,0.00565185022302994,-0.0556614712613576,-0.0335062183870803,3.26397851970789e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23445.Omega-6 Fatty Acids,40030,-0.0422606601365253,0.0055686115468474,-0.0531751387683462,-0.0313461815047044,3.40368610878846e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40030,-0.0481198889913881,0.00561855034365458,-0.0591322476649511,-0.0371075303178251,1.18613064034228e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40030,-0.0128523594378435,0.00593187696068593,-0.024478838280788,-0.00122588059489911,0.0302759125329385
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23448.Saturated Fatty Acids,40030,-0.0344895758375883,0.00589834473494745,-0.0460503315180853,-0.0229288201570913,5.09519729311654e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23449.Linoleic Acid,40030,-0.028798408421745,0.00551800033982983,-0.0396136890878115,-0.0179831277556785,1.82207009681884e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23450.Docosahexaenoic Acid,40030,-0.0568220134460969,0.00593718309199685,-0.0684588923064107,-0.045185134585783,1.21974396082422e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40030,-0.0350136548354269,0.00564656974897355,-0.046080931543415,-0.0239463781274387,5.7567391217675e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40030,0.000108096333914932,0.00631163980292409,-0.0122627176798163,0.0124789103476462,0.986335912995257
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40030,-0.017034054300732,0.00634090172569297,-0.0294622216830902,-0.00460588691837377,0.00723080835400991
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40030,0.0359494458030337,0.00623192499312908,0.0237348728165007,0.0481640187895667,8.14525417022989e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40030,-0.0134234495467001,0.00589051936424644,-0.0249688675006231,-0.00187803159277705,0.0226910738635133
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40030,0.00538185239124625,0.00606013819764217,-0.0064960184761324,0.0172597232586249,0.374514550308558
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40030,-0.0373146320677573,0.00601874951200753,-0.0491113811112921,-0.0255178830242226,5.79848931088123e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40030,-0.0294474406926753,0.0063051131952207,-0.0418054625553079,-0.0170894188300428,3.03114906807728e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40028,0.0314459786531815,0.00562363284829301,0.0204236582705272,0.0424682990358359,2.28562006653951e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23460.Alanine,40037,0.0174179497699628,0.00537822660088699,0.00687662563222432,0.0279592739077013,0.00120367417659359
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23461.Glutamine,39997,0.00161424318991863,0.00544085613615409,-0.00904983483694339,0.0122783212167806,0.766707775983929
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23462.Glycine,40024,0.0266614069664126,0.00519066575192193,0.0164877020926456,0.0368351118401796,2.83410311966938e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23463.Histidine,40024,-0.00517151231508142,0.00530535971310936,-0.0155700173527758,0.00522699272261292,0.329688864658655
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40034,0.0039018084234133,0.00542863727404078,-0.00673832063370663,0.0145419374805332,0.472308542020395
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23465.Isoleucine,40040,0.0067544665198488,0.00532377397472448,-0.00368013047061117,0.0171890635103088,0.204553994332681
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23466.Leucine,40041,0.00022636717811131,0.00543126395783237,-0.0104189101792401,0.0108716445354627,0.966755491638593
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23467.Valine,40034,0.00430315375867506,0.00547159075580367,-0.00642116412270014,0.0150274716400503,0.431613590674265
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23468.Phenylalanine,40041,0.0377146817367543,0.00528161400805383,0.0273627182809688,0.0480666451925398,9.69237106746921e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23469.Tyrosine,40025,0.0304326078375993,0.00531810058995831,0.020009130681281,0.0408560849939176,1.06925110159293e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23470.Glucose,40012,0.00901326361448591,0.0056325210773329,-0.00202647769708657,0.0200530049260584,0.109570453267346
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23471.Lactate,40012,0.00526729754998148,0.0052838182898433,-0.00508898629811138,0.0156235813980743,0.318841498967557
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23472.Pyruvate,39999,-0.00340326162624718,0.00545387453282751,-0.0140928557105891,0.00728633245809474,0.532631452311817
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23473.Citrate,40042,0.0164847140285719,0.00540909196331866,0.00588289378046732,0.0270865342766765,0.00231067762731641
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23474.3-Hydroxybutyrate,39847,-0.008538196836722,0.00509658910643406,-0.0185275114853328,0.00145111781188876,0.093900268965747
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23475.Acetate,40030,-0.007588661709676,0.0054839634466873,-0.0183372300651831,0.00315990664583111,0.166442149232649
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23476.Acetoacetate,40043,-0.0202925262246907,0.00527281987638277,-0.0306272531824009,-0.00995779926698043,0.000119309923762504
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23477.Acetone,40043,-0.0230478210537814,0.00530475782844951,-0.0334451463975424,-0.0126504957100203,1.40319073565919e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23478.Creatinine,39569,0.0377064596875698,0.00623114593600383,0.0254934136530023,0.0499195057221373,1.47084699672328e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23479.Albumin,40043,-0.0547264383647005,0.00547121271938875,-0.0654500152947024,-0.0440028614346985,1.74703288673208e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23480.Glycoprotein Acetyls,40044,0.0262050267937101,0.00583276613149899,0.0147728051759721,0.0376372484114482,7.08222887245352e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40044,0.0188372851294105,0.00582797683705133,0.0074144505287899,0.0302601197300311,0.0012308897386062
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40044,0.0203141682767641,0.00582764907128985,0.00889197609703601,0.0317363604564922,0.000491969937794257
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40044,0.0193096995549587,0.00573585909723377,0.00806741572438055,0.0305519833855369,0.000763158510076302
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40044,0.0199072796171284,0.00572537032294529,0.00868555378415567,0.0311290054501012,0.000508383800527598
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40044,0.0229240819536311,0.00569228208165045,0.0117672090735963,0.034080954833666,5.67070519508046e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40044,0.0147264423471941,0.00575082964726266,0.00345481623855933,0.025998068455829,0.0104539504241816
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40044,0.0185408186902644,0.0058699500323965,0.00703571662676723,0.0300459207537615,0.00158831942448146
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40044,0.00413146698905444,0.00572296561538348,-0.00708554561709718,0.0153484795952061,0.470360543828402
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40044,0.00523416415987627,0.00574033545850658,-0.00601689333879663,0.0164852216585492,0.361876524176953
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40044,0.00681496119234713,0.00568711821930951,-0.0043317905174995,0.0179617129021938,0.230812477554855
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40044,0.00257578418569351,0.00552607729107063,-0.00825532730480492,0.0134068956761919,0.64114012977954
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40044,0.000192992911570842,0.0054142081692499,-0.010418855100159,0.0108048409233007,0.971565372823464
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40044,0.00571135041473393,0.0056467291933846,-0.00535623880429988,0.0167789396337677,0.311819661729803
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40044,0.00507147892781693,0.00580768598612686,-0.00631158560499171,0.0164545434606256,0.382548050020432
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40044,-0.000522684280331591,0.00567217892691912,-0.0116401549770931,0.0105947864164299,0.926581028580035
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23496.Total Lipids in Large VLDL,40044,-0.00272415045750645,0.00566351363504547,-0.0138246371821956,0.00837633626718268,0.63052319804455
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23497.Phospholipids in Large VLDL,40044,0.00223603807803493,0.00562943282824606,-0.00879765026532734,0.0132697264213972,0.691221835574812
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23498.Cholesterol in Large VLDL,40044,-0.0031079403826703,0.00547102441793426,-0.0138311482418214,0.00761526747648085,0.569993688843856
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40044,-0.00435241867984705,0.00534097731819788,-0.0148207342235149,0.00611589686382079,0.415135969496275
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40044,-0.0020628517899255,0.0056108156463791,-0.0130600504568285,0.00893434687697753,0.713134510236924
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23501.Triglycerides in Large VLDL,40044,-0.00520505450144682,0.00575464355064155,-0.0164841558607043,0.00607404685781061,0.365746205653629
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40044,-0.0211658726521803,0.00538121270013486,-0.0317130495444446,-0.010618695759916,8.41536826829726e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40044,-0.0189442059480426,0.00544006380953471,-0.0296067310147307,-0.0082816808813546,0.000498395413326438
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40044,-0.0208759299563651,0.00536688512597657,-0.0313950248032791,-0.010356835109451,0.000100757277635566
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40044,-0.0269489094168487,0.00539978211451576,-0.0375324823612996,-0.0163653364723978,6.0796781479915e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40044,-0.0290494273889436,0.00548721995205418,-0.0398043784949698,-0.0182944762829174,1.21281388858003e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40044,-0.0233340958429571,0.00535070938551587,-0.0338214862385682,-0.012846705447346,1.3033838383797e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40044,-0.0104347558477024,0.00564810546811875,-0.0215050425652151,0.000635530869810391,0.0646966890827303
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40044,-0.00702647137165386,0.00542414591712156,-0.0176577973692121,0.0036048546259044,0.195199374545496
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23510.Total Lipids in Small VLDL,40044,-0.0103214161333805,0.00539312977865814,-0.0208919504995504,0.000249118232789503,0.0556629527216148
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23511.Phospholipids in Small VLDL,40044,-0.0190385344909995,0.00532758838083121,-0.0294806077174287,-0.00859646126457032,0.000353203510086395
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23512.Cholesterol in Small VLDL,40044,-0.0150229866618205,0.00526676487212051,-0.0253458458111767,-0.00470012751246434,0.00434457978025956
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40044,-0.00981395445837054,0.00523643126671309,-0.0200773597411282,0.000449450824387113,0.0609258906743534
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40044,-0.0241924857407266,0.00533403171258552,-0.0346471878973942,-0.0137377835840589,5.78963290678465e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23515.Triglycerides in Small VLDL,40044,0.00162359226075662,0.00559410539428979,-0.00934085431205137,0.0125880388335646,0.771642088122275
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40044,-0.00860009457732099,0.00545251087090264,-0.0192870158842902,0.00208682672964819,0.114753160979353
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40044,-0.00778227399275119,0.00544964707399802,-0.0184635822577873,0.00289903427228494,0.153302487842645
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40044,-0.00160888303654839,0.00544058203523436,-0.0122724238256077,0.00905465775251095,0.767448685988744
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40044,-0.0165180010089959,0.0055427156590385,-0.0273817237007114,-0.00565427831728046,0.00288572451497507
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40044,-0.0199149764351166,0.00558087911469742,-0.0308534994999235,-0.00897645337030964,0.000360204676834645
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40044,-0.00854584968943184,0.00546417094367452,-0.0192556247390339,0.00216392536017022,0.117842748077127
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40044,0.00594423270036855,0.00554860369986243,-0.00493103055136182,0.0168194959520989,0.284050043603866
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23523.Concentration of IDL Particles,40044,-0.0295574434142185,0.00546066309436998,-0.0402603430791837,-0.0188545437492534,6.29660314280669e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23524.Total Lipids in IDL,40044,-0.0427261774475037,0.0056007268381835,-0.0537036020503434,-0.031748752844664,2.50826037778099e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23525.Phospholipids in IDL,40044,-0.0373932156276657,0.00562281848448839,-0.048413939857263,-0.0263724913980685,3.02298576312172e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23526.Cholesterol in IDL,40044,-0.0466833753024169,0.00560239170400715,-0.0576640630422709,-0.0357026875625629,8.54969288389948e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40044,-0.047691083687384,0.00558728917609121,-0.0586421704725228,-0.0367399969022452,1.52077029340966e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23528.Free Cholesterol in IDL,40044,-0.0426337065269575,0.00563906389819282,-0.0536862717674154,-0.0315811412864995,4.24084980820539e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23529.Triglycerides in IDL,40044,-0.00022879860374953,0.0056270101822807,-0.0112577385610197,0.0108001413535206,0.967566852091068
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23530.Concentration of Large LDL Particles,40044,-0.0327937117907404,0.00541701236692343,-0.0434110560299104,-0.0221763675515705,1.44677347731648e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23531.Total Lipids in Large LDL,40044,-0.0514872731148094,0.00546359686161953,-0.0621959229635837,-0.0407786232660352,4.95346969541139e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23532.Phospholipids in Large LDL,40044,-0.0500192426569606,0.00543666444661165,-0.0606751049723194,-0.0393633803416018,4.01116073987541e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23533.Cholesterol in Large LDL,40044,-0.0535408238268572,0.0054778543059549,-0.0642774182665288,-0.0428042293871856,1.68858018575921e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40044,-0.0530276923459523,0.00545676447459587,-0.0637229507161602,-0.0423324339757444,2.92852009827524e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40044,-0.0535657057326979,0.00553134347278184,-0.0644071389393503,-0.0427242725260455,4.06904810341315e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23536.Triglycerides in Large LDL,40044,-0.0112873635595659,0.00570541905993705,-0.0224699849170425,-0.000104742202089291,0.0479058647194526
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40044,-0.0330398806845251,0.00537857622964141,-0.0435818900946223,-0.022497871274428,8.30126641515709e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23538.Total Lipids in Medium LDL,40044,-0.0458165337923043,0.00539518608959743,-0.0563910985279153,-0.0352419690566934,2.21007834237744e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23539.Phospholipids in Medium LDL,40044,-0.0461840500840212,0.0053568679231564,-0.0566835112134077,-0.0356845889546346,7.23763508761734e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23540.Cholesterol in Medium LDL,40044,-0.0470822263217461,0.0053931333242036,-0.0576527676371851,-0.036511685006307,2.80044901336353e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40044,-0.0442019082968366,0.00541405629192139,-0.0548134586290025,-0.0335903579646707,3.47880193500448e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40044,-0.0524480495713004,0.00539000349904549,-0.0630124564294296,-0.0418836427131713,2.58377741576924e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23543.Triglycerides in Medium LDL,40044,-0.0105879804451904,0.00579080094233823,-0.0219379502921734,0.000761989401792494,0.0675065641554195
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23544.Concentration of Small LDL Particles,40044,-0.0252075353341778,0.00536463801657027,-0.0357222258466556,-0.0146928448217001,2.63887730588605e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23545.Total Lipids in Small LDL,40044,-0.0412144062174131,0.00540699140709888,-0.0518121093753269,-0.0306167030594993,2.63242903338096e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23546.Phospholipids in Small LDL,40044,-0.0438863360280033,0.00537767952523203,-0.0544265878974581,-0.0333460841585486,3.57935404280593e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23547.Cholesterol in Small LDL,40044,-0.0418352015524223,0.00539098142285636,-0.0524015251412207,-0.0312688779636238,9.0016935452472e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40044,-0.0383020898898682,0.00542758647135399,-0.0489401593737221,-0.0276640204060144,1.77393618564063e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40044,-0.0473888951904649,0.00535732437499765,-0.0578892509654603,-0.0368885394154696,1.00620394922019e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23550.Triglycerides in Small LDL,40044,0.000240203984008795,0.00584053015641595,-0.0112072351225665,0.0116876430905841,0.967195108223056
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40044,-0.01056362913594,0.0062444829517792,-0.0228028157214273,0.00167555744954719,0.0907281408752838
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40044,-0.00569454135208448,0.00628831797816871,-0.0180196445892952,0.0066305618851262,0.365175024364308
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40044,-0.000672101398812076,0.00629474865344581,-0.0130098087595659,0.0116656059619417,0.914971424492376
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40044,-0.0130634859457882,0.00624477823352978,-0.0253032512835065,-0.000823720608069784,0.0364631042541505
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40044,-0.0180760512332867,0.006343427623121,-0.0305091693746038,-0.00564293309196951,0.00438355152682433
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40044,0.0042248978106345,0.00582241410139415,-0.00718703382809803,0.015636829449367,0.468078678145902
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40044,0.0106016823670242,0.00564687868525233,-0.000466199856070401,0.0216695645901187,0.0604763102613799
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23558.Concentration of Large HDL Particles,40044,-0.0329753076134087,0.00661175474895808,-0.0459343469213665,-0.0200162683054509,6.18629282369894e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23559.Total Lipids in Large HDL,40044,-0.0319409288994901,0.00657951586891868,-0.0448367800025707,-0.0190450777964095,1.217974001114e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23560.Phospholipids in Large HDL,40044,-0.0322335780266812,0.00649553779932946,-0.0449648321133669,-0.0195023239399954,7.03548917730188e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23561.Cholesterol in Large HDL,40044,-0.0329946800416318,0.00657648865294244,-0.045884597801399,-0.0201047622818646,5.30436966574798e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40044,-0.0339167221340144,0.0065581868050317,-0.0467707682718765,-0.0210626759961522,2.34893452808696e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40044,-0.0291556123863444,0.00656838194497001,-0.0420296409984857,-0.0162815837742032,9.10904553872015e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23564.Triglycerides in Large HDL,40044,0.010229786808631,0.00558106388169804,-0.000709098399497178,0.0211686720167591,0.0668297092316462
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40044,-0.0601408114908899,0.00590383343670942,-0.0717123250268404,-0.0485692979549395,2.70774408427071e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23566.Total Lipids in Medium HDL,40044,-0.0586388020883753,0.00585326362390112,-0.0701111987912215,-0.0471664053855291,1.49482141182073e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23567.Phospholipids in Medium HDL,40044,-0.0552755102817261,0.00582017088059961,-0.0666830452077013,-0.0438679753557509,2.46159647147904e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23568.Cholesterol in Medium HDL,40044,-0.0645334830747617,0.00591798635049696,-0.0761327363217358,-0.0529342298277877,1.37767380085499e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40044,-0.0648034031111402,0.00588797096860291,-0.0763438262096019,-0.0532629800126785,4.53221356911696e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40044,-0.061091198099524,0.00599601005111166,-0.0728433777997028,-0.0493390183993451,2.65562422529868e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23571.Triglycerides in Medium HDL,40044,0.003772361417591,0.00538929092345957,-0.00679064879238975,0.0143353716275718,0.483954229249687
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23572.Concentration of Small HDL Particles,40044,-0.0734948504004626,0.00529565421197747,-0.0838743326559385,-0.0631153681449868,1.5557334502866e-43
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23573.Total Lipids in Small HDL,40044,-0.0650795246823697,0.00536390662222202,-0.0755927816619248,-0.0545662677028145,1.00374715885989e-33
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23574.Phospholipids in Small HDL,40044,-0.0612476477310178,0.00542515050488653,-0.0718809427205954,-0.0506143527414402,1.92215608933207e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23575.Cholesterol in Small HDL,40044,-0.0759788008353481,0.00530368579617687,-0.0863740249958547,-0.0655835766748414,2.97409545758257e-46
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40044,-0.0744401469628223,0.00524366982213404,-0.0847177398142051,-0.0641625541114396,1.85666992211789e-45
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40044,-0.0679718171947192,0.00551294448585146,-0.0787771883869881,-0.0571664460024503,9.12462561132954e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23578.Triglycerides in Small HDL,40044,0.0046587471257426,0.00556177703969285,-0.00624233587205538,0.0155598301235406,0.402247759052053
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39194,0.00120401196650993,0.00507580235306696,-0.00874456064550131,0.0111525845785212,0.812500095503526
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39194,-0.000683464420981347,0.00532800728291085,-0.0111263586954866,0.00975942985352391,0.897930976588152
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39194,0.00769311767474803,0.00519545515382878,-0.00248997442675637,0.0178762097762524,0.138697271780874
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39194,-0.0137678017415682,0.00542698360002682,-0.0244046895976207,-0.00313091388551561,0.0111935982634919
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39194,0.000273503631567403,0.00516067945132552,-0.00984142809303062,0.0103884353561654,0.957734537080382
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39815,0.0132480628585431,0.00500012301113265,0.00344782175672313,0.0230483039603631,0.00806821686934571
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39815,-0.00351604559962653,0.00567411009075267,-0.0146373013775018,0.00760521017824872,0.535487765241492
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39815,-0.00622905178294646,0.00568741708695337,-0.0173763892733751,0.00491828570748214,0.273431363607227
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39815,0.00601781792555727,0.00538065459117808,-0.00452826507315175,0.0165639009242663,0.263406237382193
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39815,-0.00290107189634529,0.0054450305761438,-0.0135733318255871,0.00777118803289655,0.594184875942096
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40039,0.0249479060288942,0.00531401165872494,0.0145324431777933,0.0353633688799951,2.69218373048789e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40039,0.00255278444445217,0.00525327409540797,-0.00774363278254744,0.0128492016714518,0.627015400201348
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40039,0.00112165049885727,0.00551355532324057,-0.00968491793469425,0.0119282189324088,0.83879764861068
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40039,0.00342507507775082,0.00505155696529181,-0.00647597657422112,0.0133261267297228,0.497766764573996
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40039,-0.00988730899063273,0.00496108306305119,-0.0196110317942131,-0.000163586187052393,0.0462817111809246
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40044,-0.0152069202774389,0.00555269135938829,-0.02609019534184,-0.00432364521303788,0.00617606380028931
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40044,-0.0168980035163627,0.00580059337010311,-0.0282671665217647,-0.00552884051096056,0.00358309626017775
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40044,-0.0159444774919875,0.00584437231156549,-0.0273994472226559,-0.00448950776131913,0.00637569033714615
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40044,-0.0186373521120068,0.00567337637037821,-0.0297571697979481,-0.00751753442606552,0.00102187462247703
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40044,0.0168551266876805,0.00576018635559727,0.00556516143070984,0.0281450919446512,0.00343688710476556
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40044,-0.0341905311025425,0.0056341035899452,-0.0452333741388351,-0.0231476880662499,1.32102040814172e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40044,-0.0166158076001872,0.00552665642265785,-0.0274480541885966,-0.00578356101177784,0.0026470826211275
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40044,-0.0024973201656106,0.00537844273705174,-0.013039067930232,0.00804442759901081,0.642424762149462
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40044,-0.0326879613090734,0.00565229271540074,-0.0437664550312588,-0.0216094675868879,7.47259866239754e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40044,0.0222981417646088,0.00556807550622437,0.011384713772409,0.0332115697568085,6.23997080993839e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40044,0.053067553155354,0.00564346678658317,0.0420063582536509,0.064128748057057,6.00463378331127e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40044,-0.0293974160975015,0.00587463808639176,-0.0409117067468293,-0.0178831254481736,5.67279554631793e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40044,-0.0313284915046738,0.00591025529935003,-0.0429125918913999,-0.0197443911179478,1.16930889650888e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40044,-0.0104159709993506,0.00574582114052205,-0.0216777804347739,0.000845838436072565,0.0698833348849376
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40044,0.0204354744606701,0.00587119061790901,0.0089279408495684,0.0319430080717717,0.000501593702777547
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40044,0.0398389652246658,0.00526225560091098,0.0295249442468802,0.0501529862024513,3.91954179857601e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40044,-0.0444990290880466,0.00556820205551841,-0.0554127051168627,-0.0335853530592306,1.42426054209307e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40044,-0.0458078717238431,0.00554148197781364,-0.0566691764003578,-0.0349465670473283,1.49142197147192e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40044,-0.0134539348468481,0.00574317013503432,-0.0247105483115154,-0.00219732138218085,0.0191625473170103
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40044,0.0401883319293835,0.00576600658554211,0.028886959021721,0.051489704837046,3.29943835254685e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40044,0.015888997365144,0.00526652435673543,0.0055666096259426,0.0262113851043455,0.00255718620352876
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40044,-0.0552128262148024,0.00577462665202449,-0.0665310944527704,-0.0438945579768344,1.33303900653875e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40044,-0.0449545441124892,0.00533153094236063,-0.0554043447595161,-0.0345047434654624,3.69784303242137e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40044,-0.0217139102721664,0.00577463962987549,-0.0330322039467223,-0.0103956165976104,0.000170384803602597
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40044,0.0444079754443129,0.00574541433334457,0.0331469633509575,0.0556689875376682,1.14718032438342e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40044,0.000779619475223806,0.00520737595414204,-0.00942683739489459,0.0109860763453422,0.880991836322017
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40044,-0.038480986316132,0.00534986926311875,-0.0489667300718448,-0.0279952425604193,6.63215757681414e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40044,-0.0115019175578442,0.00543266040111376,-0.0221499319440272,-0.000853903171661216,0.0342604014110738
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40044,-0.0241736572884014,0.00588201346515281,-0.0357024036801009,-0.0126449108967019,3.98098066271509e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40044,0.0427470320077034,0.00555115788896709,0.0318667625453279,0.053627301470079,1.43576796220822e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40044,-0.000750588017451788,0.00531895700105677,-0.0111757437395231,0.00967456770461949,0.887780411944493
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40044,-0.0269363609565386,0.0053788689837757,-0.037478944164739,-0.0163937777483382,5.5653846031279e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40044,-0.00198159344064562,0.00536377820530068,-0.0124945987230349,0.0085314118417437,0.711804913038775
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40044,-0.0295754434924877,0.00575228049455728,-0.04084991326182,-0.0183009737231555,2.75827582910791e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40044,0.0379892634695583,0.00568876770398512,0.0268392787697475,0.0491392481693691,2.50510303243873e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40042,0.0207663373736413,0.00613594489234091,0.00873988538465315,0.0327927893626295,0.000715163127611869
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40042,-0.0322662587178808,0.00611676655411855,-0.0442551211639531,-0.0202773962718084,1.34493192845843e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40042,-0.0613241743915082,0.00611168416078288,-0.0733030753466427,-0.0493452734363738,1.2753683769644e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40042,0.0286410519629928,0.00650374534005711,0.0158937110964809,0.0413883928295047,1.07090049119946e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40042,0.0148998744458409,0.00611263580798526,0.00291910826218976,0.026880640629492,0.0147981409909867
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40044,0.00454000386947041,0.00636777860974905,-0.00794084220563772,0.0170208499445785,0.475878027475573
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40044,-0.0242511395564951,0.00632463595507131,-0.0366474260284349,-0.0118548530845553,0.00012636977934194
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40044,-0.0282589949826984,0.0063897583694701,-0.0407829213868598,-0.015735068578537,9.82050321198662e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40044,-0.00208641093859027,0.00613720586101734,-0.0141153344261843,0.00994251254900372,0.733890440958159
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40044,0.0373651256458168,0.00613944212983705,0.0253318190713361,0.0493984322202974,1.18418210864907e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40044,0.0462627012152776,0.00597561516310293,0.0345504954955958,0.0579749069349593,1.03919895956173e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40044,-0.0437960983031518,0.00582801104352866,-0.055218999948468,-0.0323731966578357,6.01073974362091e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40044,-0.0380454822163223,0.0057980690018784,-0.0494096974600039,-0.0266812669726406,5.48560729058442e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40044,-0.0506315428721772,0.00626304761114498,-0.0629071161900214,-0.0383559695543331,6.71518448221689e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40044,0.0387051193058709,0.00567921955027129,0.0275738489873391,0.0498363896244026,9.7570578499228e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40044,0.0238795287200185,0.0055697461151429,0.0129628263343384,0.0347962311056986,1.81892434489598e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40044,-0.0421842872790465,0.00556455382553926,-0.0530908127771034,-0.0312777617809895,3.6246227956049e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40044,-0.0404856021605989,0.00558586690086139,-0.0514339012862872,-0.0295373030349105,4.43245410685526e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40044,-0.00818043457496951,0.00568353822052915,-0.0193201694872066,0.00295930033726763,0.150079737086672
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40044,0.0389936559707594,0.00567440096464555,0.0278718300800541,0.0501154818614646,6.57733367808738e-12
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51271,-0.00173665018748164,0.00461355141047608,-0.0107792109520147,0.00730591057705147,0.706604891827725
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51271,-0.00246434553257523,0.00452470245583512,-0.0113327623460121,0.0064040712808616,0.586003905197325
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49438,0.00656441262284883,0.00433428165140878,-0.00193077941391239,0.01505960465961,0.129903358075428
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49438,-0.000326109462534736,0.00471610385493158,-0.00956967301820064,0.00891745409313117,0.944872314445374
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49438,-0.00112670114415857,0.00462622583019042,-0.0101941037713318,0.00794070148301466,0.807584061032902
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49438,0.00723483670518424,0.00423732227709112,-0.00107031495791436,0.0155399883682828,0.0877587226579341
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24009.Traffic intensity on the nearest road,51271,-0.0170973125501263,0.0384660087008687,-0.092490689603829,0.0582960645035764,0.656700280906743
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24010.Inverse distance to the nearest road,51271,0.00456437360667354,0.00403081473529297,-0.00333602327450067,0.0124647704878478,0.257489043668324
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24011.Traffic intensity on the nearest major road,51271,0.0064965736655987,0.00404417021433138,-0.0014299999544908,0.0144231472856882,0.108196812070996
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24012.Inverse distance to the nearest major road,51271,0.00206574553263781,0.00410834916131831,-0.00598661882354607,0.0101181098888217,0.615097457270198
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24013.Total traffic load on major roads,51271,-0.00220218562028791,0.0268819795149356,-0.0548908654695618,0.0504864942289859,0.934710531590409
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24015.Sum of road length of major roads within 100m,51271,0.00514921635228207,0.0260567668467339,-0.0459220466673164,0.0562204793718806,0.84334754425947
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51271,-0.0020053547335081,0.00458452516342031,-0.0109910240538119,0.0069803145867957,0.661811611453923
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51271,-0.00270805412075078,0.00457425957964639,-0.0116736028968577,0.00625749465535614,0.553842045225111
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51271,-0.00296231512441543,0.00453128710743489,-0.0118436378549878,0.00591900760615695,0.513280454965511
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51205,0.000808190043104503,0.00446376199538608,-0.00794078346785221,0.00955716355406121,0.856325141426001
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24020.Average daytime sound level of noise pollution,51271,0.00127791019539046,0.00405825363767172,-0.00667626693444611,0.00923208732522704,0.752846369328179
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24021.Average evening sound level of noise pollution,51271,0.0012791605915125,0.00405784618696904,-0.00667421793494682,0.00923253911797181,0.752588408206569
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24022.Average night-time sound level of noise pollution,51271,0.00127009286893927,0.00405818179855033,-0.00668394345621937,0.00922412919409791,0.754305193311126
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51271,0.00133448804165445,0.00405799566286053,-0.0066191834575522,0.00928815954086109,0.742268624512698
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51271,0.00131947442684223,0.00405792647359802,-0.00663406146140989,0.00927301031509436,0.745062693221218
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48390,0.00279365508524111,0.00472167358068324,-0.00646082513289803,0.0120481353033803,0.554079662197689
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48390,0.00330884502780009,0.00430842943018887,-0.00513567665537009,0.0117533667109703,0.442498728298325
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24502.Water percentage, buffer 1000m",48390,-0.00912901024631572,0.00423405657610961,-0.0174277611354905,-0.000830259357140886,0.0310865095724487
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48390,0.00175465054015719,0.00445179554106574,-0.00697086872033166,0.010480169800646,0.693477900424225
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48390,0.000919761905042506,0.00433964219814419,-0.00758593680332012,0.00942546061340513,0.832152387616902
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24505.Water percentage, buffer 300m",48390,-0.00616528331408349,0.00425703026179745,-0.0145090626272065,0.00217849599903951,0.147557666171877
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51433,-0.00291982410300589,0.00449785730750432,-0.0117356244257143,0.00589597621970258,0.516241199686849
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51433,-0.0014730231651209,0.00424678847579258,-0.00979672857767435,0.00685068224743255,0.728702367773374
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24508.Distance (Euclidean) to coast,51433,-0.00113971323558822,0.00405901218135452,-0.00909537711104308,0.00681595063986663,0.77887680074566
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35427,-0.0189083544192177,0.0286172013719334,-0.0749980691082071,0.0371813602697717,0.508796863627615
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2704.Years since last cervical smear test,45091,0.0269030260888888,0.0208955714036326,-0.0140522938622311,0.0678583460400086,0.197934875567811
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2714.Age when periods started (menarche),50781,0.0205271877771536,0.0175708773619066,-0.0139117318521834,0.0549661074064905,0.242716279513099
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2734.Number of live births,51599,0.0660764929288884,0.0168608983642802,0.0330291321348992,0.0991238537228775,8.91651251758152e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2744.Birth weight of first child,45976,-0.0185323099258342,0.0188310805901996,-0.0554412278826254,0.0183766080309571,0.325060613150628
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2754.Age at first live birth,42789,-0.00470175684609637,0.00513093904982317,-0.0147583973837498,0.00535488369155704,0.359493271522764
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2764.Age at last live birth,42738,-0.00163006154275153,0.00495602780918585,-0.0113438760487558,0.00808375296325273,0.742231381068942
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2794.Age started oral contraceptive pill,45280,0.00428901911271347,0.00557784722709291,-0.00664356145238863,0.0152215996778156,0.441938791676783
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2804.Age when last used oral contraceptive pill,43344,-0.00679401232405058,0.00484495940057728,-0.016290132749182,0.00270210810108089,0.160846685508701
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2867.Age started smoking in former smokers,29961,0.00729235449004055,0.00932328424161071,-0.0109812826235164,0.0255659916035975,0.434150730940494
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35323,-0.0223752551965259,0.0312193654535076,-0.0835652114854007,0.038814701092349,0.47356798397867
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35316,0.0135212880969549,0.0339852714832296,-0.0530898440101751,0.080132420204085,0.690743201217686
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35353,-0.00653347551051428,0.0370206037451775,-0.0790938588510622,0.0660269078300337,0.859918454795429
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35309,-0.0378984809716664,0.0353584621668114,-0.107201066818617,0.0314041048752839,0.283817423612224
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28739.Difficulty with standing for long periods,35364,0.020913862544039,0.031332879418515,-0.0404985811162505,0.0823263062043285,0.504483934620662
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28740.Difficulty with taking care of household responsibilities,35392,0.0562412782820191,0.0340988736495171,-0.0105925140710343,0.123075070635073,0.0991028624473764
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28741.Difficulty learning a new task,35283,0.0506600874075939,0.0377356055773156,-0.0233016995239447,0.124621874339133,0.179461757355945
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28742.Difficulty with joining in community activities,35009,0.0611726987031299,0.0401402721344132,-0.01750223468032,0.13984763208658,0.12754536995359
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28743.Difficulty with being emotionally affected by health problems,35318,0.011019843782663,0.0332112502820138,-0.0540742067700841,0.0761138943354101,0.740038706017067
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35386,0.0208513575951972,0.0490889389450012,-0.0753629627370052,0.1170656779274,0.671014952171852
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29932,0.019129581781934,0.0390500546440196,-0.0574085253203443,0.0956676888842124,0.624243123111613
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2897.Age stopped smoking,29974,0.0122130865934786,0.00959888129716991,-0.00660072074897446,0.0310268939359316,0.203304205288514
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34265,-0.00542140314616202,0.0136387574873957,-0.0321533678214575,0.0213105615291335,0.691007592165791
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34265,0.00581399853172112,0.0145367104377693,-0.0226779539263067,0.0343059509897489,0.68919996242451
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34265,0.0413107467310416,0.0484202225384313,-0.0535928894442837,0.136214382906367,0.393585111512099
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34265,0.00178085544728048,0.0513175400195189,-0.0988015229909766,0.102363233885538,0.972317540934828
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34265,0.0895020017239532,0.053640745767846,-0.015633859981025,0.194637863428931,0.0952394757211787
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34265,0.0248636152598784,0.044523365329796,-0.0624021807865218,0.112129411306279,0.57655690378649
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34265,0.038717346398338,0.0205286741487038,-0.00151885493312155,0.0789535477297975,0.0593227085773482
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34265,0.00869836224866965,0.0366261358166503,-0.063088863951965,0.0804855884493043,0.812281183977778
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29002.Recent lack of interest or pleasure in doing things,34195,-0.0237500409484683,0.0369969952098495,-0.0962641515597734,0.0487640696628368,0.520923915243399
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29003.Recent feelings of depression,34180,-0.0504056017017937,0.0353313307264203,-0.119655009925577,0.01884380652199,0.153711608002738
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34200,0.0228498267488246,0.029140427371395,-0.0342654108991096,0.0799650643967589,0.432984029605596
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29005.Recent feelings of tiredness or low energy,34207,0.0555047995874684,0.0297113690775042,-0.00272948380443978,0.113739082979377,0.0617734473589045
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29006.Recent poor appetite or overeating,34214,-0.0415559197418563,0.0378770573770746,-0.115794952200923,0.03268311271721,0.272613206981738
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29007.Recent feelings of inadequacy,34168,0.0402254858674453,0.0382312858930582,-0.0347078344829488,0.11515880621784,0.292751646720156
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29008.Recent trouble concentrating on things,34215,-0.0501314551152375,0.0384168102353429,-0.12542840317651,0.0251654929460346,0.191945612454067
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34202,-0.00417011321494737,0.0692289793495253,-0.139858912740017,0.131518686310122,0.951968489794001
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29010.Recent thoughts of suicide or self-harm,34139,0.0730918493600097,0.0781422204665485,-0.0800669027544253,0.226250601474445,0.349621232777961
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#0.Substances taken for depression_None of options listed,32981,0.0173284351211019,0.0257201617863333,-0.0330830819801113,0.0677399522223152,0.500501476723807
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32981,-0.0210755954523752,0.0522226820403196,-0.123432052251402,0.0812808613466513,0.686537832687768
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32981,-0.0203328967015122,0.024407888412015,-0.0681723579890616,0.0275065645860373,0.404842046491435
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32981,-0.0460185432791351,0.0711701268129979,-0.185511991832611,0.0934749052743409,0.517908809337085
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32981,-0.05100487444009,0.0446924293163033,-0.138602035900044,0.0365922870198645,0.253801300104654
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32981,-0.0666675782242392,0.0467319420075113,-0.158262184558961,0.0249270281104829,0.153733125206745
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32981,0.0146045973211729,0.0526545361159224,-0.0885982934660351,0.117807488108381,0.781505527298159
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32981,-0.0316711673904227,0.0612650814091774,-0.15175072695241,0.088408392171565,0.605202375829497
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32981,0.0210538566148851,0.0477898773738213,-0.0726143030378046,0.114722016267575,0.659549576179108
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32981,-0.0169484894005348,0.0259954776365716,-0.0678996255682152,0.0340026467671455,0.514432688269079
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32981,-0.0232834807179718,0.0397170009463886,-0.101128802572893,0.0545618411369499,0.557733377423874
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32981,-0.0826087195563365,0.0618584818101927,-0.203851343904314,0.0386339047916412,0.181765751736597
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32981,-0.0176832067368076,0.0819540853961563,-0.178313214113274,0.142946800639659,0.829172443510121
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32981,-0.0126851547706953,0.0527945915734693,-0.116162554254695,0.0907922447133045,0.810123814049908
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32981,-0.115998035399751,0.0899378981064608,-0.292276315688414,0.0602802448889121,0.197170006096692
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32981,0.00639044852005091,0.086006403187182,-0.162182101726826,0.174962998766928,0.940771821202382
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32981,0.0302460995870871,0.0452213854640621,-0.0583878159224746,0.118880015096649,0.503612431381816
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32981,-0.0216864724123356,0.0447199555055061,-0.109337585203128,0.0659646403784564,0.627731723427795
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32981,-0.0584703744446281,0.061075030154412,-0.178177433547276,0.0612366846580193,0.338416156234845
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29058.Recent feelings or nervousness or anxiety,34056,0.0079909391055849,0.0329763620998694,-0.0566427306101592,0.072624608821329,0.808534878066906
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29059.Recent inability to stop or control worrying,34068,0.00977607378844775,0.0339252346798368,-0.0567173861840325,0.0762695337609279,0.773226458157936
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29060.Recent worrying too much about different things,34058,0.0107296263973526,0.0317676052659748,-0.051534879923958,0.0729941327186631,0.735556181126706
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29061.Recent trouble relaxing,34063,-0.00102593517409036,0.0334344564836998,-0.066557469882142,0.0645055995339613,0.975521417859579
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29062.Recent restlessness,34076,0.119322465214157,0.0492255330510158,0.0228404204341663,0.215804509994148,0.0153691089046723
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29063.Recent easy annoyance or irritability,34041,-0.0181819046318118,0.0349857734650747,-0.0867540206233582,0.0503902113597347,0.603288706921085
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29064.Recent feelings of foreboding,34030,-0.00654254110611485,0.0380271671891993,-0.0810757887969454,0.0679907065847157,0.863402538790031
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32981,-0.0346951135155312,0.0254248234003399,-0.0845277673801973,0.0151375403491349,0.172409864067002
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32981,-0.00241894145879222,0.0448444078625454,-0.0903139808693811,0.0854760979517967,0.95698362518146
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32981,0.0205801767551301,0.0553190096944076,-0.0878450822459089,0.129005435756169,0.709881834059866
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32981,0.0502567827802018,0.0618512374552816,-0.0709716426321501,0.171485208192554,0.416502869344185
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#2.Symptoms of panic attack_Sweating,32981,-0.0107381570591932,0.0414084146966204,-0.0918986498645691,0.0704223357461827,0.795392242475239
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32981,-0.0383211691580756,0.0413548157888361,-0.119376608104194,0.0427342697880432,0.354137907425827
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32981,0.0461597733042906,0.0425629560851908,-0.0372636206226835,0.129583167231265,0.278171245186126
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32981,-0.0308508134272957,0.0379289716146302,-0.105191597791971,0.0434899709373796,0.416020714101059
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32981,-0.0987290160281913,0.0520850541003352,-0.200815722064848,0.00335769000846564,0.0580554038669905
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29076.Felt loved as a child,34035,-0.0308104559974124,0.0311960244623,-0.0919546639435204,0.0303337519486955,0.32335370607875
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29077.Physically abused by family as a child,34047,0.0388568408950626,0.0434193211110243,-0.046245028482545,0.12395871027267,0.370852038584223
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29078.Felt hated by family member as a child,34027,0.008700024566605,0.0401567935152043,-0.0700072907231954,0.0874073398564054,0.828484661335041
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29079.Sexually molested as a child,33920,0.0366007404710523,0.0512473480221559,-0.0638440616523733,0.137045542594478,0.47512252207548
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29080.Someone to take to doctor when needed as a child,34003,-0.049104490131554,0.0439398131341406,-0.13522652387447,0.0370175436113617,0.263791709299492
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34029,0.0349153956899149,0.053627399180318,-0.0701943067035083,0.140025098083338,0.515014457239514
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33947,0.0262474295636772,0.0404797896184655,-0.0530929580885152,0.10558781721587,0.516736617303456
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34031,0.0197434228896912,0.0451769134077527,-0.0688033273895041,0.108290173168887,0.6621033539171
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,33988,0.0298835387375209,0.0560013248519934,-0.0798790579723862,0.139646135447428,0.593615525632329
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,33997,0.0636399963347609,0.0560497273602514,-0.0462174692913318,0.173497461960854,0.25622778475371
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29086.Experienced a violent or sexual assault,34025,-0.0150878568281676,0.0523714381040604,-0.117735875512126,0.0875601618557908,0.773281611251653
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29087.Experienced a life-threatening injury or illness,34034,0.0353070450225961,0.0375769421518823,-0.0383437615950932,0.108957851640285,0.347449874528247
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29088.Experienced a marital separation or divorce,34042,0.0375535055835344,0.0330207243671649,-0.0271671141761089,0.102274125343178,0.255453515180338
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29089.Experienced the death of a spouse or partner,34051,-0.024470357889494,0.0418258741640485,-0.106449071251029,0.057508355472041,0.558525757376502
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34035,-0.024257221735284,0.0419593328264826,-0.10649751407519,0.0579830706046219,0.56320164236453
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29091.Frequency of drinking alcohol,34048,-0.0563850357825868,0.027765724205878,-0.110805855226108,-0.00196421633906601,0.0423086480691047
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32825,-0.0543212350263176,0.0341667339437617,-0.121288033556091,0.0126455635034553,0.111898119249926
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32842,-0.0617642303300377,0.0350232684511516,-0.130409836494295,0.00688137583421941,0.0778492523241776
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29104.Ever used cannabis,34041,0.0077263880597552,0.0422325154225805,-0.0750493421685026,0.090502118288013,0.854842060344269
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29108.Ever thought that life not worth living,33986,-0.0138050190974572,0.0335337820269912,-0.0795312318703599,0.0519211936754455,0.680586920142821
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29109.Ever contemplated self-harm,34024,-0.00223212517895083,0.0444496864410874,-0.0893535106034821,0.0848892602455804,0.95995059719713
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29111.Ever self-harmed,34038,0.0619090181721979,0.0689614669572785,-0.073255457064068,0.197073493408464,0.369350200914525
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34033,-0.099911640408827,0.0462599717942335,-0.190581185125525,-0.00924209569212944,0.0308139681256729
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33695,-0.0638063581761142,0.055514875767406,-0.17261551468023,0.0450027983280016,0.250438935334473
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33695,-0.0358123345738062,0.0425407567844807,-0.119192217871388,0.0475675487237759,0.399901616359837
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33695,-0.0214041052364508,0.0432839736439705,-0.106240693578633,0.0634324831057314,0.620961918431768
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33695,-0.0237768905561373,0.0554307747573899,-0.132421209080621,0.0848674279683469,0.667971450547544
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34028,-0.0726468946823221,0.0309344917604969,-0.133278498532896,-0.0120152908317481,0.0188739413293613
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X29153.Pain or discomfort today,34039,0.0289352364703905,0.0296292755662086,-0.0291381436393784,0.0870086165801594,0.328803803429694
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29154.Anxiety or depression today,34039,-0.0199147046319253,0.0354985365718486,-0.0894918363127486,0.0496624270488981,0.574810160693449
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29166.Frequency of confiding in someone close,33793,0.0240745027934164,0.0288717886828908,-0.0325142030250495,0.0806632086118822,0.404391496352574
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34001,-0.0130618769673005,0.0145759097483638,-0.0416306600740935,0.0155069061394925,0.370207136128473
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34001,-0.00802089813019082,0.0142789494369284,-0.0360076390265705,0.0199658427661889,0.574313944757067
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34001,-0.0109139576350628,0.0207827491448701,-0.0516481459590082,0.0298202306888827,0.599494559964389
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34001,0.0226481989139536,0.0182589995233561,-0.0131394401518244,0.0584358379797316,0.214863304364515
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34001,-0.0459373751621656,0.026988274002735,-0.0988343922075261,0.006959641883195,0.088764770539516
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34001,-0.000222978965575436,0.0142968563401088,-0.0282448173921888,0.0277988594610379,0.98755673282569
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34004,-0.00437757249001271,0.0158661903830862,-0.0354753056408617,0.0267201606608362,0.782626458318741
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34004,0.000239330382403377,0.022218735759039,-0.043309391705313,0.0437880524701198,0.991405931984142
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34004,-0.0700029247447721,0.0457668574071358,-0.159705965262758,0.019700115773214,0.126160033311007
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34004,0.0336225962675201,0.0305037991758523,-0.0261648501171504,0.0934100426521906,0.270383854095237
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34004,-0.0896923035274557,0.0429657407678262,-0.173905155432395,-0.00547945162251644,0.0368666211394341
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34004,0.00609738874901596,0.022666485873026,-0.0383289235621149,0.0505237010601469,0.787931960064386
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29171.Frequency of feeling 'in tune' with people,33898,0.00421641892063514,0.0360252098866476,-0.0663929924571941,0.0748258302984644,0.906830220678117
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29172.Freuency of feeling that lacks companionship,33982,0.0491846804454755,0.0323549576398484,-0.0142310365286274,0.112600397419578,0.128504194424212
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29173.Frequency of feeling left out,33924,-0.00523049503281579,0.0335312630648951,-0.0709517706400103,0.0604907805743787,0.876045325719152
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29174.Frequency of feeling isolated from others,33952,-0.0185076988402708,0.0349424370353743,-0.0869948754296043,0.0499794777490628,0.596358325320886
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29175.Tendency to bounce back quickly after hard times,34024,0.00864295253601376,0.0293443418458545,-0.048871957481861,0.0661578625538885,0.768355074110439
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29176.Ability to make it through stressful events,34024,0.012094784601175,0.028403396069172,-0.0435758716944021,0.0677654408967521,0.670247293982296
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29177.Quick recovery from stressful events,34024,0.00845702013506711,0.0288807342096844,-0.0481492189159143,0.0650632591860486,0.769661760898185
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29178.Hard to snap back when something bad happens,34024,-0.00961024744905318,0.0285835965214356,-0.065634096631067,0.0464136017329607,0.736715757063193
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29179.Comes through difficult times with little trouble,34024,0.044988096709111,0.028778324555768,-0.0114174194201942,0.101393612838416,0.118023760642114
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29180.Tendency to take a long time to get over setbacks,34024,0.00786320649262132,0.0287626407519246,-0.0485115693811509,0.0642379823663935,0.784565000500764
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29181.General happiness,33965,-0.0268773324723842,0.0301321129041819,-0.0859362737645807,0.0321816088198122,0.372424614712459
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29182.Belief that own life is meaningful,33870,0.03595373118601,0.0293371663429235,-0.02154711484612,0.0934545772181401,0.220404276501969
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29517,-0.00346818577544086,0.0394948933845915,-0.0808781768092401,0.0739418052583584,0.930028360696968
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2946.Father's age,30584,-0.0232487908507318,0.012621403983575,-0.0479867426585387,0.00148916095707517,0.0655214980521561
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2966.Age high blood pressure diagnosed,30214,-0.0114207657855369,0.010350084064632,-0.0317069305522156,0.00886539898114174,0.269879320458283
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30000.White blood cell (leukocyte) count,50730,-0.00665618127844082,0.00427727406281636,-0.0150396384415609,0.00172727588467924,0.119678843127255
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50730,0.00103589633571671,0.00501253551864584,-0.00878867328082914,0.0108604659522626,0.836276104283949
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30020.Haemoglobin concentration,50730,-0.0119108502852342,0.00544957256543339,-0.0225920125134836,-0.00122968805698473,0.0288501245634352
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30030.Haematocrit percentage,50730,-0.00952351919431759,0.00528350553052425,-0.0198791900341451,0.000832151645509951,0.0714782140810635
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30040.Mean corpuscular volume,50730,-0.00960155092833124,0.00419774761933636,-0.0178291362622305,-0.00137396559443197,0.022185633875881
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50729,-0.010466128264162,0.00420790690453064,-0.0187136257970421,-0.00221863073128195,0.0128795429548911
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50729,-0.00637670516621227,0.00412196028298727,-0.0144557473208673,0.00170233698844278,0.121873380754204
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50730,0.0200694883041614,0.00398021171060046,0.0122682733513844,0.0278707032569383,4.6298493444852e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30080.Platelet count,50730,-0.0135329056892879,0.00421900804443635,-0.0218021614563831,-0.00526364992219264,0.00134006170410893
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30090.Platelet crit,50730,-0.00247268455138116,0.00432810587777434,-0.0109557720718189,0.00601040296905654,0.567795289952742
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50730,0.0217201498755197,0.00407782820800518,0.0137276065878295,0.0297126931632098,1.010008428496e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30110.Platelet distribution width,50730,0.0233336163342239,0.00408008964202732,0.0153366406358503,0.0313305920325974,1.08379458384345e-08
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30120.Lymphocyte count,50691,-0.00217456028212733,0.0042512567943222,-0.0105070235989988,0.00615790303474418,0.608998305581985
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30130.Monocyte count,50691,0.0226070380720272,0.00431188398429239,0.0141557454628141,0.0310583306812403,1.59243387290581e-07
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30140.Neutrophill count,50691,-0.012438702355767,0.00424350842932161,-0.0207559788772374,-0.00412142583429665,0.00337913139060616
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30150.Eosinophill count,50691,0.0323287429653365,0.00417705482071958,0.0241417155167261,0.0405157704139469,1.03308197673384e-14
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30160.Basophill count,50691,-0.0120382276212115,0.0191686322837689,-0.0496087468973986,0.0255322916549756,0.529998246192407
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30170.Nucleated red blood cell count,50691,0.0146669749854113,0.0845917221131442,-0.151132800356351,0.180466750327174,0.862349787650982
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30180.Lymphocyte percentage,50691,0.0026041751753258,0.00419534175496221,-0.00561869466440012,0.0108270450150517,0.534782570770758
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30190.Monocyte percentage,50691,0.029827590099495,0.00424980942578037,0.0214979636249654,0.0381572165740245,2.29597896546185e-12
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30200.Neutrophill percentage,50691,-0.0160283316994831,0.00415730506382624,-0.0241766496245825,-0.00788001377438369,0.000115786690477621
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30210.Eosinophill percentage,50691,0.0341266533454862,0.0041303496209923,0.0260311680883413,0.0422221386026311,1.49420143901365e-16
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30220.Basophill percentage,50691,0.0018545699458454,0.00395896054331377,-0.00590499271904959,0.0096141326107404,0.639467635238173
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30230.Nucleated red blood cell percentage,50691,0.017433454953375,0.0846734527667326,-0.148526512469421,0.183393422376171,0.836878085950848
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30240.Reticulocyte percentage,50252,-0.00429159715970301,0.004335806250731,-0.0127897774111358,0.00420658309172976,0.322279348333038
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30250.Reticulocyte count,50252,-0.00453484204223503,0.00448173433635778,-0.0133190413414963,0.00424935725702623,0.311619358387483
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30260.Mean reticulocyte volume,50252,0.010439267771908,0.00415647291568808,0.00229258085715938,0.0185859546866566,0.012025642142778
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30270.Mean sphered cell volume,50252,-0.00257227535968259,0.00420233415962988,-0.0108088503125572,0.00566429959319198,0.540472800811814
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30280.Immature reticulocyte fraction,50252,-0.008942186584525,0.0043916370812645,-0.0175497952638034,-0.000334577905246571,0.0417419502366563
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50252,-0.00683802330486921,0.00445919324585997,-0.0155780420667548,0.00190199545701634,0.125173224783109
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30300.High light scatter reticulocyte count,50252,-0.00716068774978913,0.0045750169242033,-0.0161277209212276,0.00180634542164935,0.117554882201376
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30500.Microalbumin in urine,32028,0.0288657253261162,0.00810012033023711,0.0129894894788515,0.044741961173381,0.000368030161126821
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50770,-0.00684149215263667,0.00434167051994115,-0.0153511663717213,0.00166818206644798,0.115089882472486
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30520.Potassium in urine,50716,-0.00998704536250092,0.0040504090068245,-0.0179258470158769,-0.00204824370912491,0.0136813781676006
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30530.Sodium in urine,50690,-0.00930895944732744,0.00426064963552948,-0.0176598327329652,-0.00095808616168966,0.0289073007970725
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30600.Albumin,48005,-0.0561785591823388,0.00448314304817284,-0.0649655195567576,-0.0473915988079201,6.5723412604039e-36
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30610.Alkaline phosphatase,50336,0.0647549749080058,0.00423586363377729,0.0564526821858023,0.0730572676302093,1.57655897329354e-52
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30620.Alanine aminotransferase,50346,0.0168488732984667,0.00443440992981739,0.00815742983602461,0.0255403167609088,0.00014527585957771
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30630.Apolipoprotein A,47794,-0.0635493453498637,0.00490002240003478,-0.0731533892539318,-0.0539453014457955,2.48218209005298e-38
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30640.Apolipoprotein B,50239,-0.0375705344746276,0.00421252685555959,-0.0458270871115244,-0.0293139818377308,5.02053871211814e-19
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30650.Aspartate aminotransferase,50266,0.0432336292944551,0.00428967486872461,0.0348258665517549,0.0516413920371553,7.60978733075374e-24
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30660.Direct bilirubin,44584,0.00970401253859439,0.00481422991590342,0.000268121903423697,0.0191399031737651,0.0438452835647069
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30670.Urea,50331,0.0268646637879249,0.00442118741261672,0.0181991364591962,0.0355301911166537,1.24668275869856e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30680.Calcium,48013,-0.0199894609821952,0.00429966554393323,-0.0284168054483043,-0.0115621165160861,3.35236398813755e-06
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30690.Cholesterol,50344,-0.0490999074838814,0.00434594186980438,-0.057617953548698,-0.0405818614190649,1.57638334720836e-29
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30700.Creatinine,50337,0.037921668161628,0.00482236996793025,0.0284698230244847,0.0473735132987713,3.87418858115005e-15
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30710.C-reactive protein,50279,0.0227444585150702,0.00465784048685435,0.0136150911608356,0.0318738258693047,1.05082268231633e-06
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30720.Cystatin C,50341,0.109466019270128,0.0047076776800712,0.100238971017188,0.118693067523067,2.18712793492687e-118
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30730.Gamma glutamyltransferase,50340,0.00878740586119381,0.0043544368190146,0.000252709695925193,0.0173221020264624,0.0435979120822317
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30740.Glucose,47985,0.0158585749112657,0.00465587670266432,0.00673305657404367,0.0249840932484878,0.000659981267911963
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50174,0.0185205209811462,0.00471000807931284,0.009288905145693,0.0277521368165993,8.44054243071905e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30760.HDL cholesterol,47997,-0.0677265088828632,0.00515668380972067,-0.0778336091499158,-0.0576194086158107,2.89994668984607e-39
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30770.IGF-1,50201,-0.0281818892594358,0.0042523527395924,-0.0365165006290369,-0.0198472778898347,3.48481994001096e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30780.LDL direct,50289,-0.0366887377738454,0.00423814296502251,-0.0449954979852895,-0.0283819775624013,5.12991770284486e-18
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30790.Lipoprotein A,45178,-0.000975988246030392,0.00465375624501234,-0.0100973504862546,0.00814537399419379,0.833887859221218
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30810.Phosphate,47964,0.00651587553042725,0.0046288675591462,-0.0025567048854993,0.0155884559463538,0.159244747257866
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30830.SHBG,47745,0.00362366629823821,0.00488372148246159,-0.0059484278073865,0.0131957604038629,0.458101645571811
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30840.Total bilirubin,50247,-2.25164099515459e-05,0.00427691028493544,-0.008405260568425,0.00836022774852191,0.995799481972055
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30850.Testosterone,45917,0.000410141469690359,0.00756080792507371,-0.0144090420634541,0.0152293250028348,0.956739899824734
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30860.Total protein,48002,0.0553762690008536,0.00436925755741595,0.0468125241883183,0.0639400138133888,1.08506621909456e-36
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30870.Triglycerides,50335,0.00828212073990403,0.00471983269275289,-0.000968751337891635,0.0175329928176997,0.0793141163269514
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30880.Urate,50310,0.0427555711551605,0.00517887656029275,0.0326049730969867,0.0529061692133343,1.5806409035124e-16
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30890.Vitamin D,48838,-0.00186842675344808,0.0046395023513914,-0.0109618513621752,0.00722499785527906,0.687156739724424
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3137.Number of measurements made,49234,0.0320083811018711,0.0213770337080665,-0.00989060496593926,0.0739073671696815,0.134321277600885
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3143.Ankle spacing width,39847,-0.000892994461381253,0.00726045822378461,-0.0151234925799991,0.0133375036572366,0.902113273390574
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39846,-0.0116886256240734,0.00588889406685527,-0.0232308579951098,-0.000146393253037102,0.0471778584095092
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3146.Speed of sound through heel,39847,-0.0108613741299262,0.00568567927661065,-0.022005305512083,0.000282557252230729,0.0561126818909623
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39847,-0.011695608089255,0.00575561739203538,-0.0229766181776443,-0.000414598000865655,0.0421673856738154
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3148.Heel bone mineral density (BMD),39845,-0.0115064719824926,0.00574101963407901,-0.0227588704652875,-0.000254073499697773,0.0450601500840836
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3526.Mother's age at death,40579,-6.98013702640881e-05,0.00544808787191214,-0.0107480535992119,0.0106084508586837,0.989777872547786
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3581.Age at menopause (last menstrual period),39976,-0.0101526698176814,0.00542307488053557,-0.0207818965835312,0.000476556948168273,0.0612082060247627
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30079,-0.0114001424502678,0.00934829652515734,-0.0297228036395762,0.00692251873904059,0.222709855989524
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4100.Ankle spacing width (left),33194,0.0289365595880848,0.00967121486110615,0.00998097846031677,0.0478921407158529,0.00277903147284518
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33192,-0.0272168713343291,0.00791068347500043,-0.0427218109453299,-0.0117119317233283,0.000583310197342495
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4103.Speed of sound through heel (left),33194,-0.0290734393214903,0.0076975856534816,-0.0441607072023142,-0.0139861714406663,0.000159809957112087
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33194,-0.0298554550314634,0.00776309655477855,-0.0450711242788293,-0.0146397857840974,0.000121004182123689
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4105.Heel bone mineral density (BMD) (left),33192,-0.0301338212717755,0.00774114097905197,-0.0453064575907174,-0.0149611849528336,9.98781149262189e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33194,-0.0298589334646959,0.00776266705957397,-0.0450737609014608,-0.0146441060279309,0.00012067896740843
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4119.Ankle spacing width (right),33195,0.0248874553177081,0.0095568403814964,0.00615604816997517,0.0436188624654411,0.00922579487518737
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33195,-0.0163011647090881,0.00792485162002258,-0.0318338738843323,-0.000768455533843792,0.0397189223916335
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4122.Speed of sound through heel (right),33195,-0.0213375243288593,0.00774455962798501,-0.0365168611997099,-0.00615818745800867,0.0058784311504185
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33195,-0.0205007516002511,0.00780148028775871,-0.0357916529642582,-0.00520985023624404,0.00860884363127761
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4124.Heel bone mineral density (BMD) (right),33192,-0.0208033496366889,0.00778609778618217,-0.036064101297606,-0.00554259797577184,0.00755723808715416
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33195,-0.0205031117387731,0.00780150179106631,-0.0357940552492631,-0.00521216822828315,0.00860138021908287
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4194.Pulse rate,33456,0.00730089624599066,0.00754883354473366,-0.00749481750168731,0.0220966099936686,0.333492256511171
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4195.Pulse wave reflection index,33456,0.00275120772374231,0.00757862456003415,-0.0121028964139246,0.0176053118614092,0.716596944227908
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4196.Pulse wave peak to peak time,33453,-0.00822104313138424,0.00690535476210835,-0.0217555384651166,0.00531345220234812,0.233868909702316
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4198.Position of the pulse wave peak,33456,0.00975832249621881,0.00665983789211538,-0.00329495977232732,0.022811604764765,0.142887842823202
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4199.Position of pulse wave notch,33456,0.00721199190505934,0.0074517062705658,-0.00739335238524963,0.0218173361953683,0.333154802731145
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4200.Position of the shoulder on the pulse waveform,33456,0.0128641181281297,0.00665802967673396,-0.000185620038268887,0.0259138562945282,0.0533759217923492
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4269.Number of triplets attempted (left),33360,0.17770492174245,0.0897873380567717,0.00172173915117743,0.353688104333722,0.0478270123633091
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4270.Volume level set by participant (left),33273,0.00472514350301374,0.0291366436251361,-0.052382678002253,0.0618329650082805,0.871174239698821
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4276.Number of triplets attempted (right),33360,0.0914177765017533,0.0886594354941558,-0.082354717066792,0.265190270070299,0.302516501719086
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4277.Volume level set by participant (right),33253,-0.00657566123170106,0.0291523494969518,-0.0637142662457265,0.0505629437823244,0.82154736526274
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4288.Time to answer,33529,-0.000314490675373316,0.00841676628470976,-0.0168113525934044,0.0161823712426578,0.970194971012784
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4290.Duration screen displayed,33529,0.00562465728681363,0.00749689180177644,-0.0090692506446682,0.0203185652182954,0.453114422998891
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X46.Hand grip strength (left),51522,-0.0329655662989318,0.00613978323363956,-0.0449995414368653,-0.0209315911609982,7.9748787711183e-08
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X47.Hand grip strength (right),51522,-0.0302937070216135,0.00612372404162898,-0.0422962061432063,-0.0182912079000206,7.58400716269558e-07
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X48.Waist circumference,51607,0.0187142959343929,0.0081977721226533,0.00264666257399239,0.0347819292947933,0.0224468130945418
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X4803.Tinnitus,33369,0.00591154678016767,0.0357718907441517,-0.0642013590783697,0.076024452638705,0.868745638373102
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4825.Noisy workplace,33502,0.0585924888271358,0.0513799570647438,-0.0421122270197621,0.159297204674034,0.254159718638043
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4836.Loud music exposure frequency,33445,0.00944089136474855,0.0591449531157287,-0.10648321674208,0.125364999471577,0.873181691896497
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X49.Hip circumference,51604,-0.00445146148394276,0.00695342774002191,-0.0180801798543857,0.00917725688650018,0.522059479314249
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X50.Standing height,51602,0.0205983726625717,0.00569473991422351,0.00943668243069363,0.0317600628944498,0.000298476626500879
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X5057.Number of older siblings,32450,-0.0443031049463728,0.0312159480183572,-0.105486363062353,0.0168801531696074,0.15586632565308
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X51.Seated height,51482,0.0152334675058664,0.00571204755721224,0.00403785429373044,0.0264290807180024,0.00765997168474403
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5181.Ever had eye surgery,30554,-0.0667461162235368,0.0695656230953141,-0.203094737490352,0.0696025050432788,0.33736014115024
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5186.Duration visual-acuity screen displayed (right),30536,0.0138130176566466,0.00873312565860376,-0.00330390863421675,0.03092994394751,0.113774425858536
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5188.Duration visual-acuity screen displayed (left),30538,0.00327517813695018,0.00865167227080316,-0.013682099513824,0.0202324557877244,0.705027741926341
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5190.Duration at which refractometer first shown (right),30463,0.0063769154557674,0.00873496162266887,-0.0107436093246636,0.0234974402361984,0.465391099888659
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5193.Duration at which refractometer first shown (left),30464,0.00562408949036102,0.00877784801656219,-0.0115804926221009,0.0228286716028229,0.521732982851659
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5199.logMAR, initial (right)",30519,-0.00508661983043319,0.037095434333356,-0.077793671123811,0.0676204314629446,0.890938494583537
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5200.Final number of letters displayed (right),30519,0.427962560368639,0.209806779601211,0.0167412723502648,0.839183848387013,0.0414141120598061
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5201.logMAR, final (right)",30470,0.000196205641345435,0.00909340132532535,-0.0176268609562923,0.0180192722389831,0.982786330943127
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5202.Number of rounds to result (right),30519,-0.00891648159728365,0.0350281251511227,-0.0775716068934842,0.0597386436989169,0.799077728995795
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5206.logMAR, initial (left)",30516,0.0124445580567433,0.0372594914704922,-0.0605840452254215,0.0854731613389081,0.738393380199116
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5207.Final number of letters displayed (left),30516,-0.188323813875761,0.233072475504392,-0.645145865864369,0.268498238112847,0.419119191088558
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5208.logMAR, final (left)",30454,0.00402617423271262,0.00901687983437701,-0.0136469102426663,0.0216992587080915,0.65524121806662
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5209.Number of rounds to result (left),30514,-0.00647960173803388,0.0347265053798288,-0.0745435522824984,0.0615843488064307,0.851988744600906
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30227,-0.00108258863061646,0.00898857515910472,-0.0187001959424617,0.0165350186812288,0.904138387646109
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30227,-0.00427518597813824,0.00906202060549609,-0.0220367463649106,0.0134863744086341,0.637109064150502
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5256.Corneal hysteresis (right),30227,-0.00741012241909583,0.00897390846193375,-0.024998983004486,0.0101787381662943,0.40898524826663
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5257.Corneal resistance factor (right),30227,-0.00692630723978151,0.0089936011462707,-0.0245537654864721,0.0107011510069091,0.441249984427561
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30225,-0.0038807043327774,0.00893565585981205,-0.021394589818009,0.0136331811524542,0.664090979116592
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30225,-0.0054471002103854,0.00888874836549733,-0.0228690470067602,0.0119748465859894,0.540027134129873
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5264.Corneal hysteresis (left),30225,0.00192536288751118,0.00911756262362796,-0.0159450598547996,0.019795785629822,0.832761457849562
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5265.Corneal resistance factor (left),30225,0.000361376524363236,0.00900641565535229,-0.0172911981601273,0.0180139512088537,0.96799538080965
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29820,-0.122474137554735,0.163139137079692,-0.442226846230931,0.197278571121462,0.45284551927116
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51519,-0.019851977225468,0.024073702204968,-0.0670364335472053,0.0273324790962692,0.409587059493243
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51519,0.0158747542832239,0.0248381160918659,-0.0328079532568333,0.064557461823281,0.522744581694168
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51519,-0.0176902082428712,0.0620704221557403,-0.139348235668122,0.10396781918238,0.775644620029261
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51519,-0.000751898959213072,0.0104342088784823,-0.0212029483610385,0.0196991504426123,0.942553938647592
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51519,0.000873684869171098,0.00954309227214585,-0.0178307759842348,0.019578145722577,0.927055026379807
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36968,-0.0222803812505577,0.0118721996979689,-0.0455498926585768,0.000989130157461427,0.0605845012518703
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36968,-0.0130240254237902,0.0297467460843689,-0.0713276477491533,0.0452795969015728,0.661516892502901
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36968,0.017655038835277,0.0232466139354729,-0.02790832447825,0.0632184021488039,0.447587481686985
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36968,0.0168091171973907,0.0142573186850661,-0.0111352274253389,0.0447534618201203,0.238427892041775
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51598,0.0219070284758821,0.0196027062678496,-0.0165142758091032,0.0603283327608674,0.263768598903675
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51598,0.0219070284758821,0.0196027062678496,-0.0165142758091032,0.0603283327608674,0.263768598903675
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51598,-0.0221597303453879,0.0156951899398797,-0.0529223026275521,0.00860284193677621,0.157996655284076
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51598,-0.0419304629225536,0.0246224034317565,-0.0901903736487964,0.00632944780368926,0.0885908420171295
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51598,-0.0319479854058887,0.0608524119094387,-0.151218712748389,0.0873227419366111,0.59958211898725
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51598,-0.0268265644134265,0.0415991835403459,-0.108360964152504,0.0547078353256514,0.519009111084439
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51598,0.0944804437062972,0.0684991960326968,-0.0397779805177886,0.228738867930383,0.167815877050519
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51519,0.00322269787801489,0.0126411618067104,-0.0215539792631375,0.0279993750191673,0.798773816778843
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51519,0.0328872818445399,0.0209967942830214,-0.00826643495018209,0.0740409986392619,0.117290058177589
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51519,0.0305491963875321,0.0112000061964701,0.00859718424245067,0.0525012085326135,0.00638370126617536
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51519,0.0270114633194499,0.0207269057312012,-0.0136132719137045,0.0676361985526042,0.19251494470648
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51519,0.0147207048670828,0.0201663668787094,-0.0248053742151876,0.0542467839493532,0.465419021584452
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51519,0.0503591396573456,0.0113335015927099,0.0281454765356342,0.0725728027790571,8.89045347734321e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31691,0.113200656815045,0.0436586755042477,0.0276296528267196,0.198771660803371,0.00953740881628929
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31691,-0.0303508094719159,0.0283751842550569,-0.0859661706118274,0.0252645516679955,0.284823753246171
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31691,0.0400031670014341,0.0361046447251836,-0.0307619366599257,0.110768270662794,0.267907949941967
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31691,0.00729948355986281,0.0321443892372194,-0.0557035193450872,0.0703024864648128,0.82036466649229
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51509,0.043107411654777,0.0309704111841545,-0.0175945942661658,0.10380941757572,0.163967092563595
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51509,-0.0369948238551473,0.0524691066462199,-0.139834272881738,0.0658446251714436,0.480767634661246
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51509,0.252066451472011,0.084966407917165,0.0855322919543677,0.418600610989655,0.00301316679038918
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51509,0.0610218831129095,0.0828997660039475,-0.101461658254828,0.223505424480647,0.461680882709709
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51509,-0.0221645587213565,0.0258301674994539,-0.0727916870202862,0.0284625695775733,0.390851432273005
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51509,-0.0514879660282261,0.0368267829013718,-0.123668460514915,0.0206925284584625,0.162090905819041
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51509,-0.00547261059574844,0.0182695780942818,-0.0412809836605407,0.0303357624690439,0.76452446255971
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33750,0.0337130610776025,0.028075938340957,-0.0213157780706733,0.0887419002258784,0.229866645752975
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33750,0.00849007087275112,0.0324521385940258,-0.0551161207715394,0.0720962625170416,0.793621587162603
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33750,0.0729852772512249,0.0423219502697701,-0.00996574527752449,0.155936299779974,0.0846462765563313
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33750,0.000487898898878307,0.0145974768136612,-0.0281231556558976,0.0290989534536542,0.973337580025348
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37225,0.0327825386215009,0.0145904205465427,0.00418531435027724,0.0613797628927245,0.0246663924010631
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37225,-0.0449489248224208,0.0127357449816354,-0.069910984986426,-0.0199868646584155,0.000418043921794734
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37225,-0.00160550559893243,0.0119462061295142,-0.0250200696127803,0.0218090584149154,0.893092668634986
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37225,0.0630210931895023,0.0285600503928183,0.00704339441957848,0.118998791959426,0.0273585527788813
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37225,0.00732248607776491,0.0172514311212859,-0.0264903189199555,0.0411352910754854,0.671239902754528
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37225,-0.0127827886829865,0.0199290312293419,-0.0518436898924966,0.0262781125265236,0.521264301754252
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51519,-0.00327579191525872,0.0274782450458919,-0.0571331522052069,0.0505815683746895,0.905106688245171
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51519,-0.00815931293237053,0.0177475354185173,-0.0429444823526644,0.0266258564879233,0.645704079860129
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51519,-0.074590675826909,0.0684008239570581,-0.208656290782743,0.0594749391289249,0.275505381650156
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51519,-0.00392559940860455,0.0174975632530115,-0.0382208233845071,0.030369624567298,0.82248572872365
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51519,-0.018585357571428,0.0209036617069372,-0.0595565345170249,0.0223858193741689,0.373959503952275
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51519,0.0753475190439303,0.0235003740706454,0.0292867858654653,0.121408252222395,0.00134644328001148
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51519,0.0145913438746953,0.00833511963738484,-0.00174549061457899,0.0309281783639696,0.0800285745077515
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28720,0.0215886160621342,0.0284429089101224,-0.0341594854017058,0.0773367175259741,0.447885035882346
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28720,0.00112730269853327,0.0378360810609612,-0.0730314161809507,0.0752860215780173,0.976232431057851
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28720,-0.00402945421146762,0.0250140223302472,-0.0530569379787521,0.0449980295558169,0.872031859271238
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28720,0.00194007378680763,0.0226002805309604,-0.0423564760538747,0.04623662362749,0.931595322874971
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51638,-0.0146794600660066,0.00951074226194888,-0.0333205148994264,0.00396159476741316,0.122730594773964
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51638,1.62018152348222e-06,0.0253202902063202,-0.0496261486228641,0.0496293889859111,0.9999489458484
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51638,0.000275242248255629,0.00926748882349432,-0.0178890358457932,0.0184395203423045,0.976306716660048
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51638,0.00376570867604166,0.00925264938251319,-0.0143694841136842,0.0219009014657675,0.6840206878257
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51638,-0.00146397362754098,0.0133571428427279,-0.0276439735992877,0.0247160263442057,0.91272559247731
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51638,0.00516407708300703,0.0118188865688733,-0.0180009405919847,0.0283290947579988,0.66216245682149
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51638,0.0157149058084847,0.00991158320290803,-0.003711797269215,0.0351416088861845,0.112862331627596
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51638,0.112897633149218,0.027004849212214,0.0599681286932785,0.165827137605157,2.91595197457124e-05
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43170,-0.0300147254625893,0.00986413927242963,-0.0493484384365514,-0.0106810124886272,0.00234703209354813
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43170,0.00868066505059867,0.0109150345647474,-0.0127128026963062,0.0300741327975035,0.426452398118315
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43170,0.0159210907719123,0.0109745468595241,-0.00558902107275501,0.0374312026165796,0.146872160430597
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43170,0.00988373039780918,0.0140123687831046,-0.0175805124170757,0.0373479732126941,0.48059651914183
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43170,-0.0336478563266545,0.0099324564526901,-0.053115470973927,-0.0141802416793819,0.000706349110631635
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51402,-0.0176716135448724,0.0100213815866209,-0.0373135214546493,0.00197029436490457,0.0778459061106252
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51402,-0.0134568158619516,0.00806441580892012,-0.0292630708474351,0.0023494391235318,0.0951952218639179
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51402,-0.0106984715333586,0.00882451034863386,-0.027994511816681,0.00659756874996374,0.225385746493025
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51402,-0.021875881246219,0.019285447154105,-0.0596753576682649,0.0159235951758268,0.256670153068806
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51414,-0.028237389523335,0.00909705653352265,-0.0460676203290394,-0.0104071587176306,0.00191111958715345
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51414,-0.0398361259575421,0.0163540233929505,-0.0718900118077251,-0.00778224010735904,0.0148628285761362
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51519,-0.0208542757040463,0.00870751135822707,-0.0379209979661714,-0.00378755344192129,0.0166282344182143
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51519,-0.0315415736147863,0.00987743428530019,-0.0509013448139747,-0.0121818024155979,0.0014081950779323
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51519,-0.000167284648346095,0.0129244044256903,-0.0254991173226991,0.0251645480260069,0.989673111876894
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51519,-0.0260790494316582,0.0186369451983003,-0.0626074620203268,0.0104493631570105,0.161728516014898
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51519,0.0159021665219136,0.0192851952425305,-0.0218968161534462,0.0537011491972733,0.409617928478407
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51519,-0.0783927976319703,0.0247414030403568,-0.12688594759107,-0.0298996476728709,0.00153405306841594
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39847,-0.0116918034180291,0.00575561793338336,-0.0229728145674605,-0.0004107922685977,0.0422343743795208
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X864.Number of days or week walked 10+ minutes,51009,-0.00187107917846982,0.0173292727470725,-0.035836453762732,0.0320942954057924,0.914018584307691
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X874.Duration of walks,47002,-0.00539626763641158,0.0044621348247032,-0.0141420518928298,0.00334951662000669,0.226542388676689
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49951,-0.0353080742341202,0.0168872119523874,-0.0684070096607995,-0.00220913880744099,0.0365543251418764
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X894.Duration of moderate activity,43888,-0.00727077022336152,0.0206650451740322,-0.0477742587644647,0.0332327183177417,0.724962772421489
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X90087.No-wear time bias adjusted average acceleration,30341,-0.006538903346073,0.00923456052380859,-0.0246386419727378,0.0115608352805918,0.478917165687088
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49944,-0.057670464714532,0.0173002466215869,-0.0915789480928424,-0.0237619813362216,0.000858811721286243
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X914.Duration of vigorous activity,37862,0.00430334129125158,0.00593370433673236,-0.00732671920874385,0.015933401791247,0.468319368725947
